Shimoda Hiroki, Fukuda Shohei, Yafuso Daiki, Yamamoto Kouhei, Ishikawa Yudai, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. Durable Disease Control With Nivolumab in Malignant Epithelioid Angiomyolipoma: A Case Report(タイトル和訳中) IJU Case Reports. 2026.03; 9 (2): iju5.70170. ( ichushi )

Tanabe Kenji, Yoshida Soichiro, Chen Wei, Yajima Shugo, Sato Hiroyuki, Hirakawa Akihiro, Fukushima Hiroshi, Yasuda Yosuke, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. ARASENS試験における臨床的純利益のベイズ多基準意思決定分析　全体および日本人サブグループの結果(Bayesian Multi-Criteria Decision Analysis of Net Clinical Benefit in ARASENS: Overall and Japanese Subgroup Results) International Journal of Urology. 2026.02; 33 (2): iju.70384. ( ichushi )

Yajima Shugo, Yoshida Soichiro, Chen Wei, Hirose Kohei, Hirakawa Akihiro, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Tanaka Hajime, Masuda Hitoshi, Fujii Yasuhisa. 進行性尿路上皮癌のアジア人および日本人患者におけるアベルマブ維持療法のベイズ再解析　JAVELIN Bladder 100試験からのエビデンス(Bayesian reanalysis of avelumab maintenance therapy in Asian and Japanese patients with advanced urothelial carcinoma: evidence from the JAVELIN Bladder 100 trial) Japanese Journal of Clinical Oncology. 2026.02; 56 (2): 216-220. ( ichushi )

Chen Wei, Yoshida Soichiro, Yajima Shugo, Tanabe Kenji, Fujiwara Motohiro, Fukushima Hiroshi, Tanaka Hajime, Hirakawa Akihiro, Masuda Hitoshi, Fujii Yasuhisa. 転移性去勢抵抗性前立腺癌のエンザルタミド+ラジウム223併用療法による生存に対する遅延効果　PEACE-3試験の再構築患者データを用いた時間依存性解析(Delayed Survival Benefit of Enzalutamide Plus Radium-223 in Metastatic Castration-Resistant Prostate Cancer: A Time-Dependent Analysis of Reconstructed Individual Patient Data From the PEACE-3 Trial) International Journal of Urology. 2026.02; 33 (2): iju.70376. ( ichushi )

Soma Takahiko, Tanaka Hajime, Nakamura Yuki, Numao Noboru, Inoue Masaharu, Yoshinaga Atsushi, Kawamura Naoko, Tanabe Kenji, Izumi Keita, Yamamoto Takanobu, Uehara Sho, Maezawa Yuya, Toide Masahiro, Takazawa Ryoji, Araki Saori, Kitabayashi Ryo, Hirakawa Akihiro, Yoshida Soichiro, Koga Fumitaka, Fujii Yasuhisa. Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study(YUSHIMA Study)(タイトル和訳中) International Journal of Urology. 2026.01; 33 (1): iju.70329. ( ichushi )

Ishikawa Yudai, Tanaka Hajime, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. 筋層非浸潤性膀胱癌における経口5-アミノレブリン酸蛍光膀胱鏡検査の診断性能に関する膀胱部位特異的解析(Bladder region-specific analysis of the diagnostic performance of oral 5-aminolevulinic acid fluorescence cystoscopy in non-muscle-invasive bladder cancer) Japanese Journal of Clinical Oncology. 2026.01; 56 (1): 97-103. ( ichushi )

Tanaka Hiroki, Kobayashi Masaki, Matsumoto Shunya, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. Impact of Approach Routes in MRI-Ultrasound Fusion Prostate Biopsy on Post-Biopsy on Post-Biopsy Complications: A Propensity Score-Matched Analysis(タイトル和訳中) International Journal of Urology. 2026.01; 33 (1): iju.70275. ( ichushi )

Yasuda Yosuke, Wang Zijie, Yoshida Soichiro, Chen Wei, Tanaka Hajime, Fujii Yasuhisa. PROpel試験とTALAPRO-2試験のShiny法を用いた間接比較　転移性去勢抵抗性前立腺癌における比較解析(Indirect Comparison of PROpel and TALAPRO-2 Trials Using the Shiny Method: A Comparative Analysis in Metastatic Castration-Resistant Prostate Cancer) International Journal of Urology. 2025.11; 32 (11): 1709-1711. ( ichushi )

Naoki Fujita, Yuto Matsushita, Takahiro Kojima, Yukari Bando, Takahiro Osawa, Tomokazu Sazuka, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Yoshihide Kawasaki, Takuma Kato, Makito Miyake, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Hiroshi Kitamura, Hideaki Miyake, Shingo Hakakeyama, . Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study. Int J Urol. 2025.10; 32 (10): 1506-1517. ( PubMed, DOI )

Kimura Tomoki, Fujiwara Motohiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Tanabe Kenji, Izumi Keita, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 腎機能障害を伴う局所進行/転移性上部尿路上皮癌に対する一次治療の実診療成績(ゆしまSTUDY)(Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study)) International Journal of Urology. 2025.10; 32 (10): 1369-1378. ( ichushi )

Yasuda Yosuke, Numao Noboru, Matsumoto Shunya, Tamiya Takashi, Nakamura Yuki, Tanaka Hajime, Yoshida Soichiro, Kobayashi Shuichiro, Takazawa Ryoji, Matsuoka Yoh, Yonese Junji, Fujii Yasuhisa. 転移性ホルモン感受性前立腺癌患者における3剤併用療法の有効性と安全性に関する予備報告　ゆしまStudy(Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study) International Journal of Urology. 2025.10; 32 (10): 1413-1418. ( ichushi )

Fujita Naoki, Matsushita Yuto, Kojima Takahiro, Bando Yukari, Osawa Takahiro, Sazuka Tomokazu, Goto Keisuke, Numakura Kazuyuki, Yamana Kazutoshi, Kandori Shuya, Kawasaki Yoshihide, Kato Takuma, Miyake Makito, Fujita Kazutoshi, Ueda Kosuke, Tanaka Hajime, Tomida Ryotaro, Kitamura Hiroshi, Miyake Hideaki, Hakakeyama Shingo. 転移性腎細胞癌一次免疫腫瘍併用療法後の二次チロシンキナーゼ阻害薬療法の有効性と安全性に対する腎機能障害の影響　日本の多施設共同後ろ向き研究(Impact of Impaired Renal Function on the Efficacy and Safety of Second-Line Tyrosine Kinase Inhibitor Therapy After First-Line Immuno-Oncology Combination Therapy in Metastatic Renal Cell Carcinoma: A Japanese Multicenter Retrospective Study) International Journal of Urology. 2025.10; 32 (10): 1506-1517. ( ichushi )

Saitta C, Musso G, Garofano G, Tanaka H, Patil D, Meagher MF, Vourganti S, Cherullo E, Liss M, Paciotti M, Lughezzani G, Buffi NM, Master V, Fujii Y, McKay RR, Derweesh IH. Propensity Score-Matched Analysis of Neoadjuvant vs. Adjuvant Therapy in Renal Cell Carcinoma. Cancers. 2025.10; 17 (21): ( PubMed, DOI )

Srisopitsawat Pavarut, Obi Takashi, Lee Joong-Sun, Tanaka Hajime, Matsuoka Yoh, Fuji Yasuhisa. 医用画像データ拡張に用いるStable Diffusionモデルを使用してのControlNet支援インペインティング法(ControlNet-Assisted Inpainting for Medical Image Augmentation Using Stable Diffusion Models) 日本医用画像工学会大会予稿集. 2025.08; 44回 289-290. ( ichushi )

Shugo Yajima, Shinro Hata, Naoya Masumori, Yoh Matsuoka, Atsuro Sawada, Jun Miki, Mitsuhiro Tambo, Yasuyuki Kobayashi, Ayumu Matsuda, Keita Nakane, Takashi Kobayashi, Hajime Tanaka, Noriya Yamaguchi, Go Kaneko, Russell Miller, Takehiro Seto, Hiroaki Ito, Eiji Kikuchi. Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan. Int J Urol. 2025.06; 32 (6): 688-697. ( PubMed, DOI )

Masayuki Takahashi, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Shimpei Yamashita, Hisanori Taniguchi, Keisuke Monji, Ryo Ishiyama, Yoshihide Kawasaki, Takuma Kato, Shuichi Tatarano, Kimihiko Masui, Eijiro Nakamura, Tomoyuki Kaneko, Makito Miyake, Goshi Kitano, Takanobu Motoshima, Yusuke Shiraishi, Satoru Kira, Takaya Murashima, Hiroaki Hara, Masafumi Matsumura, Hiroshi Kitamura, Hideaki Miyake, Junya Furukawa, . Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2025.06; 23 (3): 102322. ( PubMed, DOI )

Tanabe Kenji, Yoshida Soichiro, Kimura Tomoki, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Izumi Keita, Fujiwara Motohiro, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Fujii Yasuhisa. オリゴ転移型尿路上皮癌における予後因子および既存の予測モデルの効果(YUSHIMA研究)(Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)) International Journal of Clinical Oncology. 2025.06; 30 (6): 1237-1246. ( ichushi )

Yajima Shugo, Hata Shinro, Masumori Naoya, Matsuoka Yoh, Sawada Atsuro, Miki Jun, Tambo Mitsuhiro, Kobayashi Yasuyuki, Matsuda Ayumu, Nakane Keita, Kobayashi Takashi, Tanaka Hajime, Yamaguchi Noriya, Kaneko Go, Miller Russell, Seto Takehiro, Ito Hiroaki, Kikuchi Eiji. 筋層浸潤性膀胱癌における根治的膀胱全摘除術後の治療に関する患者の好み　日本における離散選択実験(Patient Preferences for Post-Radical Cystectomy Treatment in Muscle-Invasive Bladder Cancer: A Discrete Choice Experiment in Japan) International Journal of Urology. 2025.06; 32 (6): 688-697. ( ichushi )

Saitta C, Autorino R, Capitanio U, Lughezzani G, Meagher MF, Yim K, Nguyen MV, Mantovani M, Guer M, Amparore D, Piramide F, Hakimi K, Patil D, Tanaka H, Fukuda S, Kobayashi M, Chen W, Pandolfo SD, Cortes J, Puri D, Yuen K, Lazzeri M, Fasulo V, Larcher A, Paciotti M, Garofano G, Porpiglia F, Montorsi F, Fujii Y, Master V, Buffi NM, Derweesh IH. Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma. Clinical genitourinary cancer. 2025.06; 23 (3): 102343. ( PubMed, DOI )

Kikuchi Hiroshi, Osawa Takahiro, Matsushita Yuto, Kojima Takahiro, Sazuka Tomokazu, Hatakeyama Shingo, Goto Keisuke, Numakura Kazuyuki, Yamana Kazutoshi, Kandori Shuya, Ueda Kosuke, Tanaka Hajime, Kurahashi Toshifumi, Bando Yukari, Kimura Takahiro, Nishiyama Naotaka, Kato Takuma, Hara Hiroaki, Ito Yoichi, Kitamura Hiroshi, Miyake Hideaki, Shinohara Nobuo. 転移性腎細胞癌に対する一次治療のニボルマブ+イピリムマブ療法後にアキシチニブで治療された五つの予後モデルの検証　日本の多施設共同後ろ向き研究(Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study) Japanese Journal of Clinical Oncology. 2025.05; 55 (5): 531-538. ( ichushi )

Hiroshi Kikuchi, Takahiro Osawa, Yuto Matsushita, Takahiro Kojima, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kosuke Ueda, Hajime Tanaka, Toshifumi Kurahashi, Yukari Bando, Takahiro Kimura, Naotaka Nishiyama, Takuma Kato, Hiroaki Hara, Yoichi Ito, Hiroshi Kitamura, Hideaki Miyake, Nobuo Shinohara. Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study. Jpn J Clin Oncol. 2025.04; 55 (5): 531-538. ( PubMed, DOI )

Waseda Yuma, Chen Wei, Yokoyama Minato, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Hirakawa Akihiro, Fushimi Kiyohide, Fujii Yasuhisa. 良性副腎腫瘍に対する腹腔鏡下副腎摘除術の転帰に手術施行件数が及ぼす影響　日本全国データベース解析(Impact of surgical volume on outcomes of laparoscopic adrenalectomy for benign adrenal tumors: A Japanese nationwide database analysis) International Journal of Urology. 2025.04; 32 (4): 409-413. ( ichushi )

Chen Wei, Tanaka Hajime, Kobayashi Masaki, Fukuda Shohei, Nakayama Akinori, Meagher Margaret F., Yoshida Soichiro, Derweesh Ithaar H., Master Viraj A., Hirakawa Akihiro, Fujii Yasuhisa, Saito Kazutaka. 非転移性淡明細胞型腎細胞癌患者の予後を予測する術前C反応性蛋白値の人種差　INMARC研究(Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC study) International Journal of Urology. 2025.04; 32 (4): 414-422. ( ichushi )

Yasujima Rikuto, Tanaka Hajime, Tsuchiya Junichi, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. 転移性尿路上皮癌患者におけるペムブロリズマブへの治療反応に対する18F-フルオロデオキシグルコースPET/CTの画像パラメータの影響(Impact of imaging parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma) International Journal of Urology. 2025.04; 32 (4): 453-455. ( ichushi )

Chen Wei, Yoshida Soichiro, Miura Noriyoshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa. 転移性ホルモン感受性前立腺癌の次世代アンドロゲン受容体軸標的療法およびアンドロゲン除去療法へのドセタキセル追加療法の有効性　腫瘍体積に特化した解析(Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis) International Journal of Urology. 2025.04; 32 (4): 361-370. ( ichushi )

Matsumoto Shunya, Ishikawa Yudai, Fukushima Hiroshi, Yamamoto Kouhei, Tsujimoto Kazutaka, Kimura Koichiro, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 経尿道的膀胱腫瘍一塊切除術で膀胱傍神経節腫を完全切除することができた1例(A case of bladder paraganglioma completely resected by transurethral endoscopic en-bloc resection of bladder tumor) IJU Case Reports. 2025.03; 8 (2): 93-96. ( ichushi )

Nakamura Yuki, Yoshida Soichiro, Arita Yuki, Takeshita Ryo, Kimura Koichiro, Kobayashi Masaki, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Jinzaki Masahiro, Fujii Yasuhisa. 膀胱画像報告データシステムに基づく高リスク筋層非浸潤性膀胱癌における2回目の経尿道的切除術の必要性(The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System) International Journal of Urology. 2025.03; 32 (3): 264-269. ( ichushi )

Isemoto K, Waseda Y, Fujiwara M, Kimura K, Hirahara D, Saho T, Takaya E, Arita Y, Kwee TC, Fukuda S, Tanaka H, Yoshida S, Fujii Y. Predictive Potential of Contrast-Enhanced MRI-Based Delta-Radiomics for Chemoradiation Responsiveness in Muscle-Invasive Bladder Cancer. Diagnostics (Basel, Switzerland). 2025.03; 15 (7): ( PubMed, DOI )

Kanami Mori, Kazuyuki Numakura, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazutoshi Yamana, Shuya Kandori, Takahiro Kimura, Naotaka Nishiyama, Yukari Bando, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Hiroshi Kitamura, Hideaki Miyake, Tomonori Habuchi. Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma. Cancer Sci. 2025.02; 116 (2): 444-452. ( PubMed, DOI )

Mori Kanami, Numakura Kazuyuki, Matsushita Yuto, Kojima Takahiro, Osawa Takahiro, Sazuka Tomokazu, Hatakeyama Shingo, Goto Keisuke, Yamana Kazutoshi, Kandori Shuya, Kimura Takahiro, Nishiyama Naotaka, Bando Yukari, Fujita Kazutoshi, Ueda Kosuke, Tanaka Hajime, Tomida Ryotaro, Kurahashi Toshifumi, Kitamura Hiroshi, Miyake Hideaki, Habuchi Tomonori. 転移性腎細胞癌患者におけるニボルマブ+イピリムマブ療法に対する一次耐性は二次治療の治療成績に影響を与える(Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma) Cancer Science. 2025.02; 116 (2): 444-452. ( ichushi )

Horie Toshinari, Fujiwara Motohiro, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 急性腎盂腎炎患者のhigh-dependency unit入室を予測するための非造影CTを用いたラジオミクス解析(Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis) International Journal of Urology. 2025.01; 32 (1): 121-123. ( ichushi )

Horie T, Fujiwara M, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis. International journal of urology : official journal of the Japanese Urological Association. 2025.01; 32 (1): 121-123. ( PubMed, DOI )

Wei Chen, Soichiro Yoshida, Noriyoshi Miura, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. Efficacy of docetaxel addition to next-generation androgen receptor-axis-targeted therapies and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: A tumor volume-specific analysis. Int J Urol. 2024.12; ( PubMed, DOI )

Cesare Saitta, Giuseppe Garofano, Jonathan A Afari, Hajime Tanaka, Dattatraya Patil, Kit L Yuen, Luke Wang, Julian Cortes, Margaret F Meagher, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Marco Paciotti, Massimo Lazzeri, Giovanni Lughezzani, Nicolò M Buffi, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2024.12; 22 (6): 102232. ( PubMed, DOI )

Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Ryo Takeshita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii. The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. Int J Urol. 2024.12; ( PubMed, DOI )

Soichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases. Int J Urol. 2024.11; 31 (11): 1234-1240. ( PubMed, DOI )

Yuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. Int J Urol. 2024.11; 31 (11): 1263-1268. ( PubMed, DOI )

Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Kousuke Tanimoto, Akira Takemoto, Takayasu Mori, Hisashi Hasumi, Mayumi Kinoshita, Takumi Kanazawa, Asuka Furukawa, Koichiro Kimura, Hiroyuki Sato, Akihiro Hirakawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Steven C Campbell, Yasuhisa Fujii. Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma. Mod Pathol. 2024.11; 37 (11): 100590. ( PubMed, DOI )

Tomoki Yanagi, Hiroaki Kikuchi, Koh Takeuchi, Koichiro Susa, Takayasu Mori, Motoko Chiga, Kouhei Yamamoto, Asuka Furukawa, Takumi Kanazawa, Yuki Kato, Naohiro Takahashi, Takefumi Suzuki, Yutaro Mori, Benjamin C Carter, Makiko Mori, Yuta Nakano, Tamami Fujiki, Yu Hara, Soichiro Suzuki, Fumiaki Ando, Shintaro Mandai, Shinya Honda, Satoru Torii, Shigeomi Shimizu, Hajime Tanaka, Yasuhisa Fujii, Tatemitsu Rai, Shinichi Uchida, Eisei Sohara. ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease. Kidney Int. 2024.11; 106 (5): 887-906. ( PubMed, DOI )

Yuya Maezawa, Masaki Kobayashi, Masanori Murakami, Ayumi Yamamura, Shotaro Naito, Hajime Tanaka, Soichiro Yoshida, Tetsuya Yamada, Yasuhisa Fujii. Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient. IJU Case Rep. 2024.11; 7 (6): 431-433. ( PubMed, DOI )

Yoshida Soichiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Tanabe Kenji, Izumi Keita, Fujiwara Motohiro, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Fujii Yasuhisa. 内臓転移を認める同時性および異時性オリゴ転移性尿路上皮癌患者の転帰および予後因子(Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases) International Journal of Urology. 2024.11; 31 (11): 1234-1240. ( ichushi )

Maezawa Yuya, Kobayashi Masaki, Murakami Masanori, Yamamura Ayumi, Naito Shotaro, Tanaka Hajime, Yoshida Soichiro, Yamada Tetsuya, Fujii Yasuhisa. 血液透析患者における褐色細胞腫切除後の遷延性低血糖(Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient) IJU Case Reports. 2024.11; 7 (6): 431-433. ( ichushi )

Nakamura Yuki, Ishikawa Yudai, Kobayashi Masaki, Fujiwara Motohiro, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 膀胱マッピング生検における光線力学診断ガイド下生検の部位特異的診断効率(Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies) International Journal of Urology. 2024.11; 31 (11): 1263-1268. ( ichushi )

Julian A Cortes, Cesare Saitta, Kit L Yuen, Dattatraya Patil, Hajime Tanaka, Dhruv Puri, Jonathan A Afari, Mirha Mahmood, Joshua Matian, Mariam Mansour, Aaron Ahdoot, Luke Wang, Margaret F Meagher, Melis Guer, Mai Dabbas, Mimi V Nguyen, Clara Cerrato, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry. Clin Genitourin Cancer. 2024.10; 22 (5): 102126. ( PubMed, DOI )

Franklin Liu, Luke Wang, Margaret F Meagher, Jonathan Afari, Cesare Saitta, Sohail Dhanji, Saeed Ghassemzadeh, Aastha Shah, Dhruv Puri, Mimi V Nguyen, Kevin Hakimi, Benjamin Schmeusser, Rachel Greenwald, Alexandra Medline, Fatima Kamal, Adil Ali, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Bo Fan, Yusuke Aida, Yuya Maezawa, Shintaro Asai, Hajime Tanaka, Dattatraya Patil, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database. Urol Oncol. 2024.10; 42 (10): 333.e21-333.e31. ( PubMed, DOI )

Hiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, Sadakatsu Ikeda, Junko Kunieda, Kenichi Ohashi, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU Case Rep. 2024.09; 7 (5): 395-398. ( PubMed, DOI )

Kenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. Int J Clin Oncol. 2024.09; 29 (9): 1302-1310. ( PubMed, DOI )

Tanaka Hiroki, Yoshida Soichiro, Aoyama Satoru, Ikeda Sadakatsu, Kunieda Junko, Ohashi Kenichi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa. オラパリブおよびペムブロリズマブによる逐次治療を行ったBRCA2変異および高腫瘍遺伝子変異量を示すダブルネガティブ前立腺癌の1例(A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab) IJU Case Reports. 2024.09; 7 (5): 395-398. ( ichushi )

Tanabe Kenji, Kobayashi Shuichiro, Maezawa Yuya, Ishihara Kensaku, Inoue Naoki, Izumi Keita, Fujiwara Motohiro, Toide Masahiro, Yamamoto Takanobu, Uehara Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numao Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. ペムブロリズマブを投与されたプラチナ製剤抵抗性転移性尿路上皮癌患者における予後予測マーカーとしてのGustave Roussy免疫スコア　ゆしまstudy(Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study) International Journal of Clinical Oncology. 2024.09; 29 (9): 1302-1310. ( ichushi )

Srisopitsawat Pavarut, Obi Takashi, Lee Joong-Sun, Kobayashi Masaki, Tanaka Hajime, Ishioka Junichiro, Matsuoka Yoh. マルチモーダル医用画像を使用する腎腫瘍セグメンテーション法の、Transformerネットーワークによる改良(Enhancing Kidney Tumor Segmentation using Multi-Modal Medical Images with Transformer Networks) 日本医用画像工学会大会予稿集. 2024.08; 43回 110-111. ( ichushi )

Masaki Kobayashi, Yoh Matsuoka, Sho Uehara, Hiroshi Tanaka, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer. Int J Urol. 2024.07; 31 (7): 739-746. ( PubMed, DOI )

Masahiro Toide, Hajime Tanaka, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Koichiro Kimura, Yuma Waseda, Soichiro Yoshida, Ukihide Tateishi, Yasuhisa Fujii. Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study. Int J Urol. 2024.07; 31 (7): 778-784. ( PubMed, DOI )

Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU Case Rep. 2024.07; 7 (4): 293-296. ( PubMed, DOI )

Toide Masahiro, Tanaka Hajime, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Kimura Koichiro, Waseda Yuma, Yoshida Soichiro, Tateishi Ukihide, Fujii Yasuhisa. 小径腎腫瘤における脂肪成分の少ない腎血管筋脂肪腫の鑑別診断のためのCTとMRIを用いた段階的アルゴリズム　前向き検証研究(Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study) International Journal of Urology. 2024.07; 31 (7): 778-784. ( ichushi )

Fujiwara Motohiro, Shimada Wataru, Yokoyama Minato, Koyanagi Anri, Shintaku Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 転移性淡明細胞型腎細胞癌患者におけるニボルマブ再投与の持続的奏効(Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma) IJU Case Reports. 2024.07; 7 (4): 293-296. ( ichushi )

Kobayashi Masaki, Matsuoka Yoh, Uehara Sho, Tanaka Hiroshi, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 臨床的限局性前立腺癌の予期せぬ前立腺外進展の予測にPI-RADSスコアと併用するMRI-超音波融合標的生検陽性コア数の有用性(Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer) International Journal of Urology. 2024.07; 31 (7): 739-746. ( ichushi )

Cesare Saitta, Jonathan A Afari, Dattatraya Patil, Hajime Tanaka, Kit L Yuen, Luke Wang, Julian Cortes, Franklin Liu, Mirha Mahmood, Joshua Matian, Mariam Mansour, Dhruv Puri, Clara Cerrato, Mimi V Nguyen, Kevin Hakimi, Masaki Kobayashi, Shohei Fukuda, Margaret F Meagher, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry. Clin Genitourin Cancer. 2024.06; 22 (3): 102098. ( PubMed, DOI )

Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, . Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. Int J Urol. 2024.05; 31 (5): 526-533. ( PubMed, DOI )

Matsushita Yuto, Kojima Takahiro, Osawa Takahiro, Sazuka Tomokazu, Hatakeyama Shingo, Goto Keisuke, Numakura Kazuyuki, Yamana Kazutoshi, Kandori Shuya, Fujita Kazutoshi, Ueda Kosuke, Tanaka Hajime, Tomida Ryotaro, Kurahashi Toshifumi, Bando Yukari, Nishiyama Naotaka, Kimura Takahiro, Yamashita Shimpei, Kitamura Hiroshi, Miyake Hideaki, the Japanese Urological Oncology Group. 一次療法の癌免疫併用療法後にチロシンキナーゼ阻害薬による二次治療を受けた転移性腎細胞癌患者の予後転帰(Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy) International Journal of Urology. 2024.05; 31 (5): 526-533. ( ichushi )

Cesare Saitta, Jonathan A Afari, Arman Walia, Dattatraya Patil, Hajime Tanaka, Kevin Hakimi, Luke Wang, Margaret F Meagher, Franklin Liu, Mimi V Nguyen, Dhruv Puri, Clara Cerrato, Ava Saidian, Masaki Kobayashi, Shohei Fukuda, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry. Urol Oncol. 2024.04; 42 (4): 119.e1-119.e16. ( PubMed, DOI )

Ishikawa Yudai, Tanaka Hajime, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa. 経口5-アミノレブリン酸を使用した経尿道的膀胱腫瘍切除術中の低血圧の発生頻度および予測因子(Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid) International Journal of Urology. 2024.03; 31 (3): 238-244. ( ichushi )

Fan Bo, Yokoyama Minato, Kobayashi Masaki, Nakamura Yuki, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 根治的腎摘除術および腎部分切除術後の新たなベースライン推算糸球体濾過量から20%低下の術後2年以内の発生率、危険因子、意義(Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years) International Journal of Urology. 2024.02; 31 (2): 119-124. ( ichushi )

Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Low Urin Tract Symptoms. 2024.01; 16 (1): e12507.

Matsuoka Y, Ueno Y, Uehara S, Tanaka H, Kobayashi M, Tanaka H, Yoshida S, Yokoyama M, Kumazawa I, Fujii Y. Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. International journal of urology : official journal of the Japanese Urological Association. 2023.12; 30 (12): 1103-1111. ( PubMed, DOI )

Matsuoka Yoh, Ueno Yoshihiko, Uehara Sho, Tanaka Hiroshi, Kobayashi Masaki, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Kumazawa Itsuo, Fujii Yasuhisa. バイパラメトリックおよびマルチパラメトリックMRIを用いた深層学習による前立腺癌検出と輪郭描出　ダイナミック造影撮像の付加価値(Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging) International Journal of Urology. 2023.12; 30 (12): 1103-1111. ( ichushi )

Chen W, Yokoyama M, Waseda Y, Kobayashi M, Fan B, Fukuda S, Tanaka H, Yoshida S, Ai M, Fushimi K, Fujii Y. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 1014-1019. ( PubMed, DOI )

Kataoka M, Yokoyama M, Waseda Y, Ito M, Kobayashi M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Tanaka H, Yoshida S, Masuda H, Fujii Y. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Lower urinary tract symptoms. 2023.11; 16 (1): e12507. ( PubMed, DOI )

Ishikawa Y, Tanaka H, Fujiwara M, Nakamura Y, Fukuda S, Waseda Y, Yoshida S, Yokoyama M, Fujii Y. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 31 (3): 238-244. ( PubMed, DOI )

Ohba K, Monji K, Osawa T, Yamana K, Yasuda Y, Tanaka H, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H, Sakai H, Eto M. Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 977-984. ( PubMed, DOI )

Ohba Kojiro, Monji Keisuke, Osawa Takahiro, Yamana Kazutoshi, Yasuda Yosuke, Tanaka Hajime, Nakagawa Yuki, Fukuyama Tamaki, Matsubara Nobuaki, Uemura Hirotsugu, Sakai Hideki, Eto Masatoshi. Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 977-984. ( ichushi )

Chen Wei, Yokoyama Minato, Waseda Yuma, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: A Japanese nationwide study(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1014-1019. ( ichushi )

Kaneko Hiroki, Fujiwara Motohiro, Tanaka Hajime, Kimura Koichiro, Yoshida Soichiro, Fujii Yasuhisa. Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma(タイトル和訳中) International Journal of Urology. 2023.11; 30 (11): 1056-1058. ( ichushi )

Sazuka T, Matsushita Y, Sato H, Osawa T, Hinata N, Hatakeyama S, Numakura K, Ueda K, Kimura T, Takahashi M, Tanaka H, Kawasaki Y, Kurahashi T, Kato T, Fujita K, Miyake M, Kojima T, Kitamura H, Miyake H, Ichikawa T. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study. Scientific reports. 2023.11; 13 (1): 20629. ( PubMed, DOI )

Fujiwara M, Tanaka H, Kobayashi M, Nakamura Y, Fan B, Ishikawa Y, Fukuda S, Toda K, Yoshida S, Yokoyama M, Yoshimura R, Fujii Y. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clinical genitourinary cancer. 2023.11; 22 (2): 193-200.e1. ( PubMed, DOI )

Kaneko H, Fujiwara M, Tanaka H, Kimura K, Yoshida S, Fujii Y. Texture feature analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2023.11; 30 (11): 1056-1058. ( PubMed, DOI )

Yamaguchi Y, Tanaka H, Kimura K, Fukuda S, Fukushima H, Waseda Y, Yoshida S, Yokoyama M, Hirakawa A, Tateishi U, Campbell SC, Fujii Y. Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2023.10; 30 (10): 913-921. ( PubMed, DOI )

Yamaguchi Yoshitomo, Tanaka Hajime, Kimura Koichiro, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Yoshida Soichiro, Yokoyama Minato, Hirakawa Akihiro, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa. Prognostic impact of the radiological infiltrative feature of primary renal tumor in metastatic renal cell carcinoma(タイトル和訳中) International Journal of Urology. 2023.10; 30 (10): 913-921. ( ichushi )

Fan B, Yokoyama M, Kobayashi M, Nakamura Y, Fujiwara M, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. International journal of urology : official journal of the Japanese Urological Association. 2023.10; 31 (2): 119-124. ( PubMed, DOI )

Kimura K, Yoshida S, Tsuchiya J, Kitazume Y, Waseda Y, Tanaka H, Yokoyama M, Toda K, Yoshimura R, Masaya I, Koga F, Tateishi U, Fujii Y. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. European radiology. 2023.09; 33 (9): 6245-6255. ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Tanaka Hajime, Yokoyama Minato, Yoshimura Ryoichi, Fujii Yasuhisa. The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer(タイトル和訳中) International Journal of Urology. 2023.07; 30 (7): 616-617. ( ichushi )

Soma Takahiko, Yoshida Soichiro, Wakejima Ryo, Taguchi Towako, Fukuda Shohei, Tanaka Hajime, Yokoyama Minato, Ohashi Kenichi, Okubo Kenichi, Fujii Yasuhisa. A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy IJU Case Reports. 2023.07; 6 (4): 216-218. ( ichushi )

Yoshida S, Takahara T, Tanaka H, Yokoyama M, Yoshimura R, Fujii Y. The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2023.07; 30 (7): 616-617. ( PubMed, DOI )

Soma T, Yoshida S, Wakejima R, Taguchi T, Fukuda S, Tanaka H, Yokoyama M, Ohashi K, Okubo K, Fujii Y. A case of repeat oligoprogressive castration-resistant prostate cancer treated with pulmonary metastasectomy. IJU case reports. 2023.07; 6 (4): 216-218. ( PubMed, DOI )

Soma T, Fukuda S, Matsuyama Y, Ikeda R, Inoue M, Waseda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujiwara T, Kageyama Y, Fujii Y. Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association. 2023.06; 30 (6): 532-538. ( PubMed, DOI )

Soma Takahiko, Fukuda Shohei, Matsuyama Yusuke, Ikeda Riko, Inoue Masaharu, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujiwara Takeo, Kageyama Yukio, Fujii Yasuhisa. ロボット支援前立腺全摘除術後の鼠径ヘルニア予防のための腹膜閉鎖および鞘状突起離断法(Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy) International Journal of Urology. 2023.06; 30 (6): 532-538. ( ichushi )

Uchida Y, Yokoyama M, Fujiwara M, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujiwara T, Fujii Y. Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer. Urology research & practice. 2023.05; 49 (3): 162-168. ( PubMed, DOI )

Nakamura Yuki, Fukushima Hiroshi, Yoshitomi Kasumi, Soma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa. 筋層非浸潤性膀胱癌の増悪予測における背側膀胱頸部浸潤の重要性(Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer) International Journal of Urology. 2023.04; 30 (4): 381-388. ( ichushi )

Fujiwara M, Yoshida S, Takahara T, Soma T, Nakamura Y, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yokoyama M, Fujii Y. Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer. Clinical & experimental metastasis. 2023.04; 40 (2): 187-195. ( PubMed, DOI )

Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study. International journal of urology : official journal of the Japanese Urological Association. 2023.03; 30 (3): 258-263. ( PubMed, DOI )

Fujiwara Motohiro, Yokoyama Minato, Toide Masahiro, Fujiwara Ryo, Tanaka Hajime, Oguchi Tomohiko, Komai Yoshinobu, Yoshida Soichiro, Matsuoka Yoh, Numao Noboru, Yamamoto Shinya, Fukui Iwao, Yonese Junji, Fujii Yasuhisa. 筋層浸潤性膀胱癌患者に対する最大限の経尿道的切除術、導入化学放射線療法、地固め部分膀胱切除術からなる選択的4者併用膀胱温存療法後の腎機能転帰と根治的膀胱全摘術後の腎機能転帰との比較　2施設後ろ向き研究(Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study) Japanese Journal of Clinical Oncology. 2023.03; 53 (3): 263-269. ( ichushi )

Chen Wei, Yokoyama Minato, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Nonomura Norio, Fujii Yasuhisa. 根治的膀胱摘除術の動向およびロボット支援根治的膀胱摘除術に注目した外科的アプローチ間の手術成績の比較　日本の全国データベース研究(Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study) International Journal of Urology. 2023.03; 30 (3): 258-263. ( ichushi )

Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Japanese journal of clinical oncology. 2023.03; 53 (3): 263-269. ( PubMed, DOI )

Yoshida, S; Takahara, T; Arita, Y; Ito, M; Hayakawa, S; Oguchi, T; Komai, Y; Numao, N; Yuasa, T; Inoue, M; Ushijima, H; Kudo, S; Shimano, Y; Nakamura, Y; Uchida, Y; Uehara, S; Tanaka, H; Yaegashi, H; Izumi, K; Yokoyama, M; Matsuoka, Y; Yoshioka, Y; Konishi, K; Nakanishi, K; Nagahara, A; Hirakawa, A; Koike, R; Koga, F; Nishimura, K; Mizokami, A; Yonese, J; Kageyama, Y; Yoshimura, R; Fujii, Y. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL) BMC UROLOGY. 2023.03; 23 (1): 33. ( PubMed, DOI )

Hajime Tanaka, Shohei Fukuda, Koichiro Kimura, Yuki Fukawa, Kouhei Yamamoto, Hiroshi Fukushima, Shingo Moriyama, Yosuke Yasuda, Sho Uehara, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Ukihide Tateishi, Steven C Campbell, Yasuhisa Fujii. Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. Eur Urol Open Sci. 2023.02; 48 36-43. ( PubMed, DOI )

Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. BJU international. 2023.02; 131 (2): 219-226. ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Progressive site-directed therapyを施行したgenuineおよびinduced oligometastasisを伴う去勢抵抗性前立腺癌の再発パターン(Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive sitedirected therapy) International Journal of Urology. 2023.02; 30 (2): 204-210. ( ichushi )

Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. International journal of urology : official journal of the Japanese Urological Association. 2023.02; 30 (2): 204-210. ( PubMed, DOI )

Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; 30 (4): 381-388. ( PubMed, DOI )

Chen W, Yokoyama M, Kobayashi M, Fan B, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Ai M, Fushimi K, Nonomura N, Fujii Y. Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot-assisted radical cystectomy: A Japanese nationwide database study Int J Urol. 2022.12;

Julia H Yuan, Hajime Tanaka, Dattatraya Patil, Kevin Hakimi, Shady Soliman, Margaret F Meagher, Ava Saidian, Arman Walia, Sohail Dhanji, Franklin Liu, Jonathan Afari, Mimi Nguyen, Luke Wang, Yosuke Yasuda, Kazutaka Saito, Yasuhisa Fujii, Viraj Master, Ithaar H Derweesh. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. Clin Genitourin Cancer. 2022.12; 21 (4): e219-e227. ( PubMed, DOI )

Yamaguchi Y, Yokoyama M, Takemoto A, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma. IJU case reports. 2022.11; 5 (6): 480-483. ( PubMed, DOI )

Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I.. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis Front Oncol. 2022.11; ( DOI )

Yamaguchi Yoshitomo, Yokoyama Minato, Takemoto Akira, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. コハク酸脱水素酵素欠損性腎細胞癌を合併したコハク酸脱水素酵素欠損性の悪性パラガングリオーマ(Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma) IJU Case Reports. 2022.11; 5 (6): 480-483. ( ichushi )

Shimada Wataru, Kimura Koichiro, Tanaka Hajime, Fukuda Shohei, Yoshida Soichiro, Fujii Yasuhisa. 不規則な腫瘍形の重要性　cT1b-2N0M0腎細胞癌のpT3aへのステージ上昇を予測するためのダイナミックCTに基づくラジオミクス解析(Significance of tumor shape irregularity: Radiomics analysis based on dynamic computed tomography for predicting pT3a upstaging in cT1b-2N0M0 renal cell carcinoma) International Journal of Urology. 2022.11; 29 (11): 1387-1389. ( ichushi )

Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma Int J Urol. 2022.08; 29 (8): 822-823.

Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab Asia Pac J Clin Oncol (IF: 2.6; Q4). 2022.08;

Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y.. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clin Genitourin Cancer. . 2022.08;

Yamamoto S, Fukushima H, Fukuda S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab. Asia-Pacific journal of clinical oncology. 2022.08; 18 (4): 410-418. ( PubMed, DOI )

Toide M, Saito K, Yasuda Y, Tanaka H, Fukuda S, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical genitourinary cancer. 2022.08; 20 (4): e276-e282. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa. 「進行性腎細胞癌の一次治療としての複合癌免疫療法の包括的評価」に対するエディトリアルコメント(Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma) International Journal of Urology. 2022.08; 29 (8): 822-823. ( ichushi )

Tanaka H, Fujii Y. Editorial Comment to Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association. 2022.08; 29 (8): 822-823. ( PubMed, DOI )

Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation Abdom Radiol (NY) (IF: 3.04; Q2). 2022.06;

Tanaka H, Fujii Y. Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. Int J Urol. 2022.06; 29 (6): 501-502.

Tanaka H, Fujii Y. Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review. International journal of urology : official journal of the Japanese Urological Association. 2022.06; 29 (6): 501-502. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa. 「転移性腎細胞癌に対する外科的局所治療　文献レビュー」に対するエディトリアルコメント(Editorial Comment to Surgical and focal treatment for metastatic renal cell carcinoma: A literature review) International Journal of Urology. 2022.06; 29 (6): 501-502. ( ichushi )

Matsumoto S, Arita Y, Yoshida S, Fukushima H, Kimura K, Yamada I, Tanaka H, Yagi F, Yokoyama M, Matsuoka Y, Oya M, Tateishi U, Jinzaki M, Fujii Y. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation. Abdominal radiology (New York). 2022.06; 47 (6): 2178-2186. ( PubMed, DOI )

Nityam Rathi, Diego A Palacios, Emily Abramczyk, Hajime Tanaka, Yunlin Ye, Jianbo Li, Yosuke Yasuda, Robert Abouassaly, Mohamed Eltemamy, Alvin Wee, Christopher Weight, Steven C Campbell. Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol. 2022.04; 40 (4): 1011-1018. ( PubMed, DOI )

Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy Urol Oncol (IF: 3.5; Q3). 2022.04;

Matsuoka Y, Uehara S, Toda K, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Yoshimura R, Kihara K, Fujii Y. Focal brachytherapy for localized prostate cancer: 5.7-year clinical outcomes and a pair-matched study with radical prostatectomy. Urologic oncology. 2022.04; 40 (4): 161.e15-161.e23. ( PubMed, DOI )

Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma Diagnostics (Basel) (IF: 5.25; Q2). 2022.03;

Uchida Y, Yoshida S, Arita Y, Shimoda H, Kimura K, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Jinzaki M, Fujii Y. Apparent Diffusion Coefficient Map-Based Texture Analysis for the Differentiation of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Diagnostics (Basel, Switzerland). 2022.03; 12 (4): ( PubMed, DOI )

Nguyen MV, Walia A, Saidian A, Puri D, Meagher MF, Hakimi K, Tanaka H, Patil D, Yasuda Y, Saito K, Dhanji S, Cerrato C, Narasimhan R, Perry J, Master V, Fujii Y, Derweesh IH. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma BJU Int. 2022.02; 131 (2): 219-226.

Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer Eur Radiol (IF: 5.32; Q1). 2022.02;

Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response 2022.01;

Kimura K, Yoshida S, Tsuchiya J, Yamada I, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Tateishi U, Fujii Y. Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. European radiology. 2022.01; 32 (1): 671-679. ( PubMed, DOI )

Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y. Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response. Cancers. 2022.01; 14 (3): ( PubMed, DOI )

Preedanan W, Suzuki K, Kondo T, Kobayashi M, Tanaka H, Ishioka J, Matsuoka Y, Fujii Y, Kumazawa I. Improvement of Urinary Stone Segmentation Using GAN-Based Urinary Stones Inpainting Augmentation. IEEE Access. 2022;

Fujiwara M, Yokoyama M, Toide M, Fujiwara R, Tanaka H, Oguchi T, Komai Y, Yoshida S, Matsuoka Y, Numao N, Yamamoto S, Fukui I, Yonese J, Fujii Y. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study Jpn J Clin Oncol. 2022;

Rossi SH, Tanaka H, Usher-Smith JA, Bernhard JC, Fujii Y, Stewart GD . Kidney Cancer Screening and Epidemiology. Société Internationale d’Urologie Journal. 2022;

Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I. Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis. Frontiers in oncology. 2022; 12 995991. ( PubMed, DOI )

Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study Diagnostics (Basel). 2021.12;

Yokoyama Minato, Ishioka Junichiro, Toba Mikayo, Fukushima Hiroshi, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. 日本におけるロボット支援腎部分切除術の政府承認後2年間の動向と安全性　2016年から2018年までの全国データベース研究(Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018) International Journal of Urology. 2021.12; 28 (12): 1268-1272. ( ichushi )

Shimada Wataru, Tanaka Hajime, Fukawa Yuki, Kimura Koichiro, Yamamoto Kouhei, Fukuda Shohei, Fukushima Hiroshi, Yasuda Yosuke, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Tateishi Ukihide, Campbell Steven C., Fujii Yasuhisa. 局所進行腎細胞癌における浸潤性腫瘍の正常腎実質との界面　臨床的意義と病理学的意味(Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications) International Journal of Urology. 2021.12; 28 (12): 1233-1239. ( ichushi )

Shimada W, Tanaka H, Fukawa Y, Kimura K, Yamamoto K, Fukuda S, Fukushima H, Yasuda Y, Uehara S, Yoshida S, Yokoyama M, Matsuoka Y, Tateishi U, Campbell SC, Fujii Y. Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implications. International journal of urology : official journal of the Japanese Urological Association. 2021.12; 28 (12): 1233-1239. ( PubMed, DOI )

Ishikawa Y, Fukushima H, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Sakai Y, Otsuka Y, Takazawa R, Yano M, Tsukamoto T, Okuno T, Noro A, Nagahama K, Kamata S, Fujii Y. Prognostic Accuracy of the qSOFA Score for In-Hospital Mortality in Elderly Patients with Obstructive Acute Pyelonephritis: A Multi-Institutional Study. Diagnostics (Basel, Switzerland). 2021.12; 11 (12): ( PubMed, DOI )

Yokoyama M, Ishioka J, Toba M, Fukushima H, Tanaka H, Yoshida S, Matsuoka Y, Ai M, Fushimi K, Fujii Y. Trends and safety of robot-assisted partial nephrectomy during the initial 2-year period after government approval in Japan: A nationwide database study from 2016 to 2018. International journal of urology : official journal of the Japanese Urological Association. 2021.12; 28 (12): 1268-1272. ( PubMed, DOI )

Maruyama Riko, Fukushima Hiroshi, Fukuda Shohei, Yasuda Yosuke, Uehara Sho, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 副腎腫瘍および腎腫瘍の清潔手術における予防的抗菌薬の不使用　連続患者1362例を対象としたリスクベース戦略の結果(Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients) International Journal of Urology. 2021.10; 28 (10): 1032-1038. ( ichushi )

Maruyama R, Fukushima H, Fukuda S, Yasuda Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patients. International journal of urology : official journal of the Japanese Urological Association. 2021.10; 28 (10): 1032-1038. ( PubMed, DOI )

Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed, DOI )

Fujiwara Motohiro, Tanaka Hajime, Yuasa Takeshi, Komai Yoshinobu, Oguchi Tomohiko, Fujiwara Ryo, Numao Noboru, Yamamoto Shinya, Fujii Yasuhisa, Fukui Iwao, Yonese Junji. 播種性胚細胞癌に対するエトポシド、イホスファミド、シスプラチンによるファーストライン併用化学療法　現在の臨床現場における有効性と実施可能性(First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice) International Journal of Urology. 2021.09; 28 (9): 920-926. ( ichushi )

Yoshida S, Matsuoka Y, Toda K, Uehara S, Tanaka H, Yokoyama M, Saito K, Yoshimura R, Fujii Y. Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy. IJU case reports. 2021.07; 4 (4): 228-230. ( PubMed, DOI )

Yoshida Soichiro, Matsuoka Yoh, Toda Kazuma, Uehara Sho, Tanaka Hajime, Yokoyama Minato, Saito Kazutaka, Yoshimura Ryoichi, Fujii Yasuhisa. 外部放射線療法後の非転移性去勢抵抗性前立腺癌に対する救済小線源療法による治療(Nonmetastatic castration-resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy) IJU Case Reports. 2021.07; 4 (4): 228-230. ( ichushi )

Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique INTERNATIONAL JOURNAL OF UROLOGY. 2021.03; 28 (3): 302-307. ( PubMed, DOI )

Yamamoto S, Yoshida S, Ishii C, Takahara T, Arita Y, Fukushima H, Tanaka H, Yokoyama M, Matsuoka Y, Fujii Y. Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer. Journal of magnetic resonance imaging : JMRI. 2021.03; 54 (2): 401-408. ( PubMed, DOI )

Sweet DE, Ward RD, Wang Y, Tanaka H, Campbell SC, Remer EM. Infiltrative Renal Malignancies: Imaging Features, Prognostic Implications, and Mimics. Radiographics : a review publication of the Radiological Society of North America, Inc. 2021.03; 41 (2): 487-508. ( PubMed, DOI )

Yasuda Yosuke, Saito Kazutaka, Tanaka Hajime, Uehara Sho, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. 連続患者356例におけるガスレス単孔式腹腔鏡下腎部分切除術の治療成績　無阻血および無縫合手技の実施可能性(Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique) International Journal of Urology. 2021.03; 28 (3): 302-307. ( ichushi )

Tanaka H, Fujii Y. Editorial Comment. The Journal of urology. 2021.02; 205 (5): 101097JU000000000000154902-1320. ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 127-129. ( PubMed, DOI )

Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. International cancer conference journal. 2021.01; 10 (1): 20-23. ( PubMed, DOI )

Yoshida Soichiro, Takahara Taro, Arita Yuki, Toda Kazuma, Yamada Ichiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Genuine- and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy INTERNATIONAL UROLOGY AND NEPHROLOGY. 2021.01; 53 (6): 1119-1125. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence INTERNATIONAL JOURNAL OF UROLOGY. 2021.01; 28 (1): 16. ( PubMed, DOI )

Fukushima Hiroshi, Yoshida Soichiro, Kijima Toshiki, Nakamura Yuki, Fukuda Shohei, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti-PD-1 Treatment Efficacy in Urothelial Carcinoma INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021.01; 22 (2): ( PubMed, DOI )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. systematic biopsyにより標的生検からアップグレードした前立腺癌の三次元解析　磁気共鳴-超音波画像融合システムを用いた標的辺縁部および周辺領域のサンプリングの可能性(Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy: Potential of target margin and surrounding region sampling using magnetic resonance-ultrasound image fusion systems) International Journal of Urology. 2021.01; 28 (1): 127-129. ( ichushi )

Soma Takahiko, Yokoyama Minato, Uchida Yusuke, Kirimura Susumu, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Fujii Yasuhisa. 膀胱増大に起因する扁平上皮癌とリンパ節転移に対して根治的膀胱切除術と腸間膜リンパ節郭清を行い長期生存した症例　1症例報告(Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report) International Cancer Conference Journal. 2021.01; 10 (1): 20-23. ( ichushi )

Tanaka Hajime, Fujii Yasuhisa. 「膀胱癌に対するリンパ節郭清　現行の基準と最新のエビデンス」に対するエディトリアルコメント(Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence) International Journal of Urology. 2021.01; 28 (1): 16. ( ichushi )

Yasuda Y, Saito K, Tanaka H, Uehara S, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Kihara K, Fujii Y. . Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless technique Int J Urol. 2020.12;

Tanaka Hajime. Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management(和訳中) International Journal of Urology. 2020.12; 27 (12): 1071. ( ichushi )

Tanaka Hajime. Editorial Comment to Retroperitoneal tumors: Review of diagnosis and management INTERNATIONAL JOURNAL OF UROLOGY. 2020.12; 27 (12): 1071. ( PubMed, DOI )

Palacios Diego Aguilar, Campbell Rebecca, Wang Yanbo, Tanaka Hajime, Ding Xiaobo, Ye Yun-Lin, Remer Erick M., Rizk Alain, Ward Ryan, Haywood Samuel, Campbell Steven C.. Infiltrative Renal Masses: Clinical Challenges UROLOGY. 2020.11; 145 3-8. ( PubMed, DOI )

Fukushima Hiroshi, Kijima Toshiki, Fukuda Shohei, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Saito Kazutaka, Matsubara Nobuaki, Numao Noboru, Sakai Yasuyuki, Yuasa Takeshi, Masuda Hitoshi, Yonese Junji, Kageyama Yukio, Fujii Yasuhisa. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study CANCER MEDICINE. 2020.11; 9 (22): 8355-8363. ( PubMed, DOI )

田中 一, 木島 敏樹, 福田 翔平, 福島 啓司, 安田 庸輔, 森山 真吾, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久. 局所限局性浸潤性膀胱癌の実践治療　筋層浸潤膀胱癌に対する4者併用膀胱温存療法 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS13-1. ( ichushi )

福島 啓司, 木島 敏樹, 安田 庸輔, 森山 真吾, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 松岡 陽, 松原 伸晃, 湯浅 健, 増田 均, 米瀬 淳二, 影山 幸雄, 藤井 靖久. 進行・転移性膀胱癌治療のup-to-date　進行尿路上皮癌に対するペムブロリズマブ治療における化学放射線療法の意義 日本癌治療学会学術集会抄録集. 2020.10; 58回 WS14-1. ( ichushi )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images(和訳中) International Journal of Urology. 2020.09; 27 (9): 760-766. ( ichushi )

Matsuoka Yoh, Uehara Sho, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 760-766. ( PubMed, DOI )

Fukushima Hiroshi, Fukuda Shohei, Moriyama Shingo, Uehara Sho, Yasuda Yosuke, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report ANTI-CANCER DRUGS. 2020.09; 31 (8): 866-871. ( PubMed, DOI )

Tanaka Hajime. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision(和訳中) International Journal of Urology. 2020.09; 27 (9): 710. ( ichushi )

Tanaka Hajime. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision INTERNATIONAL JOURNAL OF UROLOGY. 2020.09; 27 (9): 710. ( PubMed, DOI )

Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review Clin Genitourin Cancer. 2020.07;

Nakamura Yuki, Yokoyama Minato, Yoshida Soichiro, Tanaka Hajime, Kijima Toshiki, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Minami Isao, Yoshimoto Takanobu, Naito Shotaro, Ogawa Yoshihiro, Yamada Tetsuya, Uchida Shinichi, Fujii Yasuhisa. クッシング症候群患者における副腎摘除後の術後腎機能障害と長期にわたる腎機能変化(Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome) International Journal of Urology. 2020.05; 27 (5): 395-400. ( ichushi )

Tanaka Hajime, Fujii Yasuhisa. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 257. ( PubMed, DOI )

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. International journal of urology : official journal of the Japanese Urological Association. 2020.03; ( PubMed, DOI )

Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2020.03; 27 (3): 236-243. ( PubMed, DOI )

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome Int J Urol. 2020 Mar 11. doi: 10.1111/iju.14205. 2020.03;

Tanaka Hajime, Fujii Yasuhisa. 「膀胱癌に対する根治的腹腔鏡下膀胱全摘術後の腫瘍学的成績と再発パターン　日本の多施設コホート」に対するDr.TanakaとDr.Fujiiによるエディトリアルコメント(Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort) International Journal of Urology. 2020.03; 27 (3): 257. ( ichushi )

Tanaka Hajime, Fukushima Hiroshi, Kijima Toshiki, Nakamura Yuki, Yajima Shugo, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 筋層浸潤性膀胱癌の高齢患者への選択的4者併用膀胱温存療法の実行可能性と成績(Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer) International Journal of Urology. 2020.03; 27 (3): 236-243. ( ichushi )

Aguilar Palacios D, Caraballo ER, Tanaka H, Wang Y, Suk-Ouichai C, Ye Y, Lin L, Li J, Abouassaly R, Campbell SC. Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy. The Journal of urology. 2020.02; 101097JU0000000000000797. ( PubMed, DOI )

Ye Yunlin, Tanaka Hajime, Wang Yanbo, Campbell Rebecca A., Aguilar Palacios Diego, DeWitt-Foy Molly E., Mahmood Furman A., Eltemamy Mohamed, Remer Erick M., Li Jianbo, Campbell Steven C.. Split renal function in patients with renal masses: utility of parenchymal volume analysis vs nuclear renal scans BJU INTERNATIONAL. 2020.02; 125 (5): 686-694. ( PubMed, DOI )

Tanaka H, Kijima T, Fujii Y. Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives AME Medical Journal. 2020.02;

Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer. European urology focus. 2020.01; 7 (2): 366-372. ( PubMed, DOI )

Tanaka H. Editorial Comment to Retroperitoneal tumors: review of diagnosis and management Int J Urol. 2020; 27: 1071. 2020;

Tanaka H. Editorial Comment to Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association -Summary of the Revision Int J Urol. 2020. doi: 10.1111/iju.14314. 2020;

Ye Y*, Tanaka H*, Wang Y, Campbell RA, Aguilar Palacios D, Dewitt-Foy ME, Mahmood FA, Eltemamy M, Remer EM, Li J, Campbell SC. Split Renal Function in Patients with Renal Masses: Utility of Parenchymal Volume Analysis versus Nuclear Renal Scans BJU International. 2020; 125: 686-694. *Equal contribution. 2020;

Tanaka H, Fujii Y. Editorial Comment to Lymph node dissection for bladder cancer: Current standards and the latest evidence Int J Urol. 2020. doi: 10.1111/iju.14419. 2020;

Tanaka H, Fujii Y. Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns following laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort Int J Urol. 2020. doi: 10.1111/iju.14194. 2020;

Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer Int J Urol. 2020; 27: 236-243. *Equal contribution. 2020;

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 2020; 27: 760-766. 2020;

Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC) Clin Genitourin Cancer. 2020;

Fukushima H, Moriyama S, Waseda Y, Fukuda S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer Eur Urol Focus. 2020;

Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: a preliminary study Cancer Med. 2020; 9: 8355-8363. doi: 10.1002/cam4.3445. 2020;

Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report Anticancer Drugs. 2020; 31: 866-871. doi: 10.1097/CAD.0000000000000982.. 2020;

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Yokoyama M, Fujii Y. Three-dimensional analysis of systematic biopsy-derived prostate cancer upgrading over targeted biopsy Int J Urol. 2020 Oct 27. doi: 10.1111/iju.14410. 2020;

ToshikiKijimaHajimeTanakaShoUeharaSoichiroYoshidaMinatoYokoyamaJunichiroIshiokaYohMatsuokaKazutakaSaitoKazunoriKiharaYasuhisaFujii. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019.12;

Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clinical genitourinary cancer. 2019.12; ( PubMed, DOI )

Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clinical genitourinary cancer. 2019.11; ( PubMed, DOI )

Rebecca A Campbell, Molly E DeWitt-Foy, Hajime Tanaka, Yun-Lin Ye, Yanbo Wang, Jeffrey Reese, Venkatesh Krishnamurthi, Wen Dong, Steven C Campbell. Functional Recovery From Prolonged Warm Ischemia: Compelling Case Scenarios. Urology. 2019.10; 132 22-27. ( PubMed, DOI )

Toshiki Kijima, Hajime Tanaka, Fumitaka Koga, Hitoshi Masuda, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int.. 2019.08; 124 (2): 242-250. ( PubMed, DOI )

Masaki Kobayashi, Hajime Tanaka, Ukihide Tateishi, Noboru Numao, Junji Yonese, Masaya Ito, Fumitaka Koga, Hiroshi Fukushima, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma. Int. J. Urol.. 2019.08; 26 (8): 820-826. ( PubMed, DOI )

Yanbo Wang, Hajime Tanaka, Yunlin Ye, Xiaobo Ding, Ryan D Ward, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Erick M Remer, Steven C Campbell. The Complete Spectrum of Infiltrative Renal Masses: Clinical Characteristics and Prognostic Implications. Urology. 2019.08; 130 86-92. ( PubMed, DOI )

Hajime Tanaka, Xiaobo Ding, Yunlin Ye, Yanbo Wang, Rebecca A Campbell, Molly E DeWitt-Foy, Chalairat Suk-Ouichai, Ryan D Ward, Erick M Remer, Jianbo Li, Steven C Campbell. Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation. Eur Urol Oncol. 2019.08; ( PubMed, DOI )

Kobayashi Masaki, Tanaka Hajime, Tateishi Ukihide, Numao Noboru, Yonese Junji, Ito Masaya, Koga Fumitaka, Fukushima Hiroshi, Uehara Sho, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 転移性尿路上皮癌患者の化学療法感受性と生存率にPET/CTでのフルオロデオキシグルコース取り込みが及ぼす影響(Impact of fluorodeoxyglucose uptake on positron emission tomography/computed tomography on chemosensitivity and survival in patients with metastatic urothelial carcinoma) International Journal of Urology. 2019.08; 26 (8): 820-826. ( ichushi )

Yajima Shugo, Yoshida Soichiro, Takahara Taro, Arita Yuki, Tanaka Hiroshi, Waseda Yuma, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression EUROPEAN RADIOLOGY. 2019.07; 29 (7): 3881-3888. ( PubMed, DOI )

Chalairat Suk-Ouichai, Hajime Tanaka, Yanbo Wang, Jitao Wu, Yunlin Ye, Sevag Demirjian, Jianbo Li, Steven C Campbell. Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy? J. Urol.. 2019.06; 201 (6): 1088-1096. ( PubMed, DOI )

Hiroshi Watanabe, Hajime Tanaka, Yasuhisa Fujii, Makoto Kodama, Takumi Akashi, Tomoyuki Fujioka, Kazunori Kubota, Yukihisa Saida, Ukihide Tateishi. A case of immunoglobulin G4-related inflammatory pseudotumor mimicking renal cell carcinoma. Abdom Radiol (NY). 2019.04; 44 (4): 1230-1236. ( PubMed, DOI )

Hajime Tanaka, Yanbo Wang, Chalairat Suk-Ouichai, Diego Aguilar Palacios, Elvis R Caraballo, Yunlin Ye, Erick M Remer, Jianbo Li, Robert Abouassaly, Steven C Campbell. Can We Predict Functional Outcomes after Partial Nephrectomy? J. Urol.. 2019.04; 201 (4): 693-701. ( PubMed, DOI )

Elvis R Caraballo, Diego Aguilar Palacios, Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, Brian R Lane, Steven C Campbell. Open partial nephrectomy when a non-flank approach is required: indications and outcomes. World J Urol. 2019.03; 37 (3): 515-522. ( PubMed, DOI )

Jitao Wu, Chalairat Suk-Ouichai, Wen Dong, Zhiling Zhang, Hajime Tanaka, Yanbo Wang, Elvis Caraballo, Erick M Remer, Jianbo Li, Sudhir Isharwal, Robert Abouassaly, Steven C Campbell. Vascularized Parenchymal Mass Preserved with Partial Nephrectomy: Functional Impact and Predictive Factors. Eur Urol Oncol. 2019.02; 2 (1): 97-103. ( PubMed, DOI )

Naoko Kawamura, Minato Yokoyama, Hajime Tanaka, Takayuki Nakayama, Yosuke Yasuda, Toshiki Kijima, Soichiro Yoshida, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy. Int. J. Urol.. 2019.01; 26 (1): 113-118. ( PubMed, DOI )

Kawamura Naoko, Yokoyama Minato, Tanaka Hajime, Nakayama Takayuki, Yasuda Yosuke, Kijima Toshiki, Yoshida Soichiro, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 無阻血腎部分切除術後の急性腎障害と中期腎機能(Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy) International Journal of Urology. 2019.01; 26 (1): 113-118. ( ichushi )

Soma Takahiko, Ishioka Junichiro, Tanaka Hajime, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 造影CTとT2強調MRIによる脂肪に乏しい血管筋脂肪腫の診断を目的とした畳み込みニューラルネットワークアルゴリズムを用いたコンピュータ補助診断の可能性(Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging) International Journal of Urology. 2018.11; 25 (11): 978-979. ( ichushi )

Ryan D Ward, Hajime Tanaka, Steven C Campbell, Erick M Remer. 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications. Radiographics. 2018.11; 38 (7): 2021-2033. ( PubMed, DOI )

Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 230.

Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer INTERNATIONAL JOURNAL OF UROLOGY. 2018.10; 25 234.

Takahiko Soma, Junichiro Ishioka, Hajime Tanaka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Potential for computer-aided diagnosis using a convolutional neural network algorithm to diagnose fat-poor angiomyolipoma in enhanced computed tomography and T2-weighted magnetic resonance imaging. Int. J. Urol.. 2018.08; ( PubMed, DOI )

Alice Crane, Chalairat Suk-Ouichai, Jack A Campbell, Elvis R Caraballo, Diego Aguilar Palacios, Hajime Tanaka, Steven C Campbell. Imprudent Utilization of Partial Nephrectomy. Urology. 2018.07; 117 22-26. ( PubMed, DOI )

Hajime Tanaka, Soichiro Yoshida, Fumitaka Koga, Kazuma Toda, Ryoichi Yoshimura, Yutaka Nakajima, Emiko Sugawara, Takumi Akashi, Yuma Waseda, Masaharu Inoue, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys.. 2018.06; ( PubMed, DOI )

Chalairat Suk-Ouichai, Jitao Wu, Wen Dong, Hajime Tanaka, Yanbo Wang, J J H Zhang, Elvis Caraballo, Erick Remer, Jianbo Li, Sudhir Isharwal, Steven C Campbell. Tumor Contact Surface Area As a Predictor of Functional Outcomes After Standard Partial Nephrectomy: Utility and Limitations. Urology. 2018.06; 116 106-113. ( PubMed, DOI )

Moriyama Shingo, Yoshida Soichiro, Tanaka Hajime, Tanaka Hiroshi, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. T2強調MRIにおける小径腎腫瘍の信号強度比曲線解析　脂肪成分の少ない腎血管筋脂肪腫と腎細胞癌との鑑別(Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma) International Journal of Urology. 2018.06; 25 (6): 554-560. ( ichushi )

Yajima Shugo, Yoshida Soichiro, Tanaka Hiroshi, Tanaka Hajime, Inoue Masaharu, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. pT1膀胱癌の進行に関する拡散強調MRI上のinchworm sign欠如の予測的意義(Predictive significance of absence of inchworm sign on diffusion-weighted MRI for progression of the pT1 bladder cancer) 日本泌尿器科学会総会. 2018.04; 106回 IS-75. ( ichushi )

Yasuda Yosuke, Saito Kazutaka, Soma Takahiko, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Kihara Kazunori, Fujii Yasuhisa. ガスレス単孔式腹腔鏡下clampless無縫合腎部分切除術　周術期転帰(Gasless laparoendoscopic single-port clampless sutureless partial nephrectomy: Perioperative outcomes) 日本泌尿器科学会総会. 2018.04; 106回 IS-68. ( ichushi )

Shingo Moriyama, Soichiro Yoshida, Hajime Tanaka, Hiroshi Tanaka, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii. Intensity ratio curve analysis of small renal masses on T2-weighted magnetic resonance imaging: Differentiation of fat-poor angiomyolipoma from renal cell carcinoma. Int. J. Urol.. 2018.03; ( PubMed, DOI )

Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction. Urol. Int.. 2018.01; 100 (1): 85-91. ( PubMed, DOI )

Yoh Matsuoka, Junichiro Ishioka, Hiroshi Tanaka, Tomo Kimura, Soichiro Yoshida, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer. AJR Am J Roentgenol. 2017.08; 209 (2): W76-W84. ( PubMed, DOI )

Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hiroshi Tanaka, Mihiro Kaga, Kotaro Watanabe, Hiroshi Fukushima, Yasukazu Nakanishi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Standardization of the apparent diffusion coefficient value of bladder cancer across different centers: Applicability in predicting aggressive pathologic phenotypes. Clin Imaging. 2017.07; 44 121-126. ( PubMed, DOI )

Hajime Tanaka, Yasuhisa Fujii, Hiroshi Tanaka, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Sho Uehara, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Junji Yonese, Kazunori Kihara. Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. Int. J. Urol.. 2017.07; 24 (7): 511-517. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa, Tanaka Hiroshi, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Uehara Sho, Numao Noboru, Yuasa Takeshi, Yamamoto Shinya, Masuda Hitoshi, Yonese Junji, Kihara Kazunori. 小径腎腫瘍中の脂肪成分の少ない腎血管筋脂肪腫診断のためのCTおよびMRIを用いたステップワイズアルゴリズム　開発および外的妥当性(Stepwise algorithm using computed tomography and magnetic resonance imaging for diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation) International Journal of Urology. 2017.07; 24 (7): 511-517. ( ichushi )

Hajime Tanaka, Yasuhisa Fujii, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara. Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques. Int. J. Urol.. 2017.06; 24 (6): 472-473. ( PubMed, DOI )

Tanaka Hajime, Fujii Yasuhisa, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. 無阻血・無縫合法による低侵襲性腎部分切除術後のCTにおける仮性腎動脈瘤の非描出(Absence of renal artery pseudoaneurysm on computed tomography after minimally-invasive partial nephrectomy using clampless and sutureless techniques) International Journal of Urology. 2017.06; 24 (6): 472-473. ( ichushi )

Tanaka Hajime, Yoshida Soichiro, Inoue Masaharu, Ito Masaya, Kijima Toshiki, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori, Fujii Yasuhisa. 免疫組織化学に基づいた分子的サブタイプ判定による筋層浸潤性膀胱癌における化学放射線療法に対する感受性の予測(Immunohistochemistry-based molecular subtypes predict therapeutic sensitivity of chemoradiotherapy in muscle-invasive bladder cancer) 日本泌尿器科学会総会. 2017.04; 105回 AOP11-07. ( ichushi )

Yuki Nakamura, Soichiro Yoshida, Hiroshi Tanaka, Masaharu Inoue, Masaya Ito, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection. Urol. Int.. 2017.03; 98 (3): 298-303. ( PubMed, DOI )

Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Yasuyuki Sakai, Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Mitsuru Koizumi, Atsushi Kohno, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol. Int.. 2016.01; 96 (1): 65-72. ( PubMed, DOI )

Shinji Urakami, Takeshi Yuasa, Shinya Yamamoto, Mizuaki Sakura, Hajime Tanaka, Tatsuro Hayashi, Sho Uehara, Yasushi Inoue, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Junji Yonese. Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1171-1178. ( PubMed, DOI )

Takeshi Yuasa, Naoko Inoshita, Hajime Tanaka, Shinji Urakami, Shinya Yamamoto, Yasuhisa Fujii, Hitoshi Masuda, Iwao Fukui, Yuichi Ishikawa, Junji Yonese. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Int. J. Clin. Oncol.. 2015.12; 20 (6): 1198-1202. ( PubMed, DOI )

Hajime Tanaka, Takeshi Yuasa, Yasuhisa Fujii, Mizuaki Sakura, Shinji Urakami, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era. Chemotherapy. 2013; 59 (6): 441-446. ( PubMed, DOI )

Yuma Waseda, Hajime Tanaka, Kazuaki Nakagomi, Shuichi Goto, Akio Ido. A case of hereditary persistence of α-fetoprotein: diagnostic usefulness of the subfraction profile. Jpn. J. Clin. Oncol.. 2012.08; 42 (8): 767-769. ( PubMed, DOI )

Yoshida Soichiro, Koga Fumitaka, Kobayashi Shuichiro, Ishii Chikako, Tanaka Hiroshi, Tanaka Hajime, Komai Yoshinobu, Saito Kazutaka, Masuda Hitoshi, Fujii Yasuhisa, Kawakami Satoru, Kihara Kazunori. Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2012.05; 83 (1): e21-e27. ( PubMed, DOI )

Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa, Ishii Chikako, Tanaka Hiroshi, Koga Fumitaka, Saito Kazutaka, Masuda Hitoshi, Kawakami Satoru, Kihara Kazunori. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011.10; 18 (10): 727-730. ( PubMed, DOI )

早稲田 悠馬, 小笠原 崚, 山口 良友, 漆戸 まどか, 松本 峻弥, 小林 正貴, 石川 雄大, 福島 啓司, 安田 庸輔, 福田 翔平, 田中 一, 吉田 宗一郎, 藤井 靖久. 前立腺全摘術後重症尿失禁に対する人工尿道括約筋植込術　PSA再発による紹介・手術介入の遅延(Artificial urinary sphincter for severe stress urinary incontinence after radical prostatectomy: Biochemical recurrence delays surgical intervention). 日本泌尿器科学会総会 2026.04.01

漆戸 まどか, 早稲田 悠馬, 松本 峻弥, 小林 正貴, 石川 雄大, 安田 庸輔, 福島 啓司, 福田 翔平, 田中 一, 吉田 宗一郎, 藤井 靖久. 上部尿路上皮癌に対する腎尿管全摘除後の腎機能改善と予後に関する検討(Impact of postoperative renal function improvement on prognosis after radical nephroureterectomy for upper tract urothelial carcinoma). 日本泌尿器科学会総会 2026.04.01

松本 峻弥, 早稲田 悠馬, 山口 良友, 漆戸 まどか, 陳 い, 小林 正貴, 石川 雄大, 福島 啓司, 安田 庸輔, 福田 翔平, 田中 一, 吉田 宗一郎, 藤井 靖久. 上部尿路上皮癌に対する腎尿管全摘除後における経時的な腎機能低下予測因子の検討(Predictors of Long-term Renal Function Decline After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma). 日本泌尿器科学会総会 2026.04.01

田宮 嵩士, 沼尾 昇, 古賀 文隆, 松岡 陽, 小林 秀一郎, 塚本 哲郎, 酒井 康之, 奥野 哲男, 高沢 亮治, 田中 一, 吉田 宗一郎, 藤井 靖久, 米瀬 淳二. リアルワールドにおける転移性去勢感受性前立腺癌患者300例の治療成績　YUSHIMA studyデータベースを用いた多施設前向き研究(Real-world prospective outcomes of 300 patients with de novo metastatic hormone-sensitive prostate cancer: YUSHIMA study). 日本泌尿器科学会総会 2026.04.01

福島 啓司, 吉田 宗一郎, 河崎 雅暢, 松本 峻弥, 小林 正貴, 石川 雄大, 安田 庸輔, 福田 翔平, 早稲田 悠馬, 田中 一, 石黒 めぐみ, 藤井 靖久. ヒドロキシラジカル含有ウルトラファインバブル水はフェロトーシスを介して膀胱腫瘍の形成を抑制する(Hydroxyl radical-containing oxygen-ultrafine bubble water prevents bladder tumor development through the induction of ferroptosis). 日本泌尿器科学会総会 2026.04.01

濱田 宇玄, 安田 庸輔, 松本 峻弥, 小林 正貴, 石川 雄大, 福島 啓司, 福田 翔平, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藤井 靖久. オリゴ転移を有する去勢抵抗性前立腺癌に対する反復進行部位標的治療の成績と安全性(Outcomes and safety profile of repeated progressive site-directed therapy for patients with oligoprogressive metastatic castration-resistant prostate cancer). 日本泌尿器科学会総会 2026.04.01

米瀬 一朗, 古賀 文隆, 田中 一, 戸出 真宏, 田邉 健児, 小林 秀一郎, 吉田 宗一郎, 藤井 靖久. 組織学的亜型を含む転移性尿路上皮癌に対するペムブロリズマブ治療におけるリンパ節転移の予後因子としての意義の解析(Lymph node metastasis as a favorable prognostic factor in patients with metastatic urothelial carcinoma containing variant histology treated with pembrolizumab). 日本泌尿器科学会総会 2026.04.01

下澤 佑揮, 菅原 江美子, 三宅 美佐代, 稲村 健太郎, 竹内 賢吾, 田宮 嵩士, 安田 庸輔, 田中 一, 大木 遼佑, 竹村 公佑, 藤原 遼, 沼尾 昇, 米瀬 淳二. 非転移性淡明細胞型腎細胞癌における腎実質浸潤進展の予後因子としての検証(External Validation of Renal Parenchymal Infiltration and Micronodular Spread as a Prognostic Factor in Non-Metastatic Clear Cell Renal Cell Carcinoma). 日本泌尿器科学会総会 2026.04.01

田中 一. 腎癌のトランスレーショナルリサーチ最前線　淡明細胞型腎細胞癌における再発リスク規定因子の形態学的探索(Translational research in kidney cancer　Morphological Exploration of Recurrence Risk Determinants in Clear Cell Renal Cell Carcinoma). 日本泌尿器科学会総会 2026.04.01

陳 信橋, 小林 正貴, 松本 峻弥, 石川 雄大, 安田 庸輔, 福島 啓司, 福田 翔平, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藤井 靖久. 限局性前立腺癌に対する片葉小線源治療後の前立腺体積変化の検討(Prostate volume changes after hemibrachytherapy for localized prostate cancer). 日本泌尿器科学会総会 2026.04.01

榊原 遼太郎, 石川 雄大, 田中 一, 山口 良友, 漆戸 まどか, 松本 峻弥, 小林 正貴, 福島 啓司, 安田 庸輔, 福田 翔平, 早稲田 悠馬, 吉田 宗一郎, 藤井 靖久. 進行腎細胞癌に対する一次ICI併用療法　real-world outcomeと予後因子の検討(Real-world outcomes and prognostic factors in patients with advanced Renal Cell Carcinoma treated with First-Line Immune checkpoint inhibitor Combination). 日本泌尿器科学会総会 2026.04.01

安田 庸輔, 吉田 宗一郎, 池田 貞勝, 米瀬 一郎, 佐野 裕大, 浦崎 哲也, 中村 祐基, 田中 一, 沼尾 昇, 松岡 陽, 古賀 文隆, 米瀬 淳二, 藤井 靖久. 転移性去勢抵抗性前立腺癌患者における包括的ゲノムプロファイリングから得られた実臨床での知見(Real-World Insights From Comprehensive Genomic Profiling in Patients With Metastatic Castration-Resistant Prostate Cancer). 日本泌尿器科学会総会 2026.04.01

御子神 友也, 安田 庸輔, 松本 峻弥, 小林 正貴, 石川 雄大, 福島 啓司, 福田 翔平, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藤井 靖久. 転移性ホルモン感受性前立腺癌日本人患者におけるARSI併用療法の有効性と安全性(Clinical outcomes of upfront doublet therapy using ARSIs in Japanese patients with mHSPC). 日本泌尿器科学会総会 2026.04.01

山口 良友, 安田 庸輔, 前澤 祐弥, 田中 大樹, 上原 翔, 高沢 亮治, 米瀬 一朗, 中村 祐基, 戸出 真宏, 沼尾 昇, 田中 一, 吉田 宗一郎, 藤井 靖久. 転移性ホルモン感受性前立腺癌におけるトリプレット療法とダブレット療法の実臨床比較　多施設前向き共同研究(YUSHIMA study)(Real-world comparison of triplet versus doublet therapy in synchronous metastatic hormone-sensitive prostate cancer from the YUSHIMA Study). 日本泌尿器科学会総会 2026.04.01

福田 翔平, 松本 峻弥, 小林 正貴, 石川 雄大, 福島 啓司, 安田 庸輔, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藤井 靖久. 膀胱温存療法後の膀胱癌再発症例に対するロボット支援救済膀胱全摘除(Clinical outcomes of salvage robotic-assisted radical cystectomy in patients after bladder-sparing therapy). 日本泌尿器科学会総会 2026.04.01

田中 一, 藤井 靖久. 腎癌診療ガイドライン2025年版の徹底解説　腎癌診療ガイドライン2025年版徹底解説　全身薬物療法(Clinical practice guideline for renal cancer: update on 2025　The 2025 Renal Cancer Clinical Practice Guidelines: Systemic Therapy). 日本泌尿器科学会総会 2026.04.01

菅原 江美子, 下澤 佑揮, 三宅 美佐代, 安田 庸輔, 田中 一, 稲村 健太郎, 沼尾 昇, 米瀬 淳二, 竹内 賢吾. 淡明細胞型腎細胞癌における腎実質浸潤・微小結節状進展(RPI/MNS)の臨床病理学的意義の検討(Prognostic significance of RPI/MNS in clear cell renal cell carcinoma: A validation study). 日本病理学会会誌 2026.03.01

パワルット・チソピットサワット , 小尾 高史, 李 中淳, 藤井 靖久, 田中 一, 小林 正貴, 松岡 陽. ControlNet誘導型インペインティングとStable Diffusionによる医用画像拡張の高度化. 日本医用画像工学会大会予稿集 2025.08.01

Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Gaku Okumura, Kaoru Ishii, Shotaro Matsuoka, Takumi Hatori, Hiroki Shimoda, Tsubasa Ito, Madoka Urushido, Rie Muta, Shunya Matsumoto, Masaki Kobayashi, Yuki Nakamura, Yudai Ishikawa, Hiroshi Fukushima, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii. Potential refinement of the UICC 8th T staging system by incorporating renal parenchymal infiltration or micronodular spread in clear cell renal cell carcinoma. AUA Annual Meeting 2025 2025.04.27

Okumura Gaku, Fukushima Hiroshi, Muta Rie, Urushido Madoka, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. CT値と化学シフトイメージングが患者選択に使われる時、副腎摘除術適応に腫瘍径4cmカットオフは適切か(Is a 4 cm cutoff in tumor diameter appropriate for the indication for adrenalectomy when CT values and chemical shift imaging are used for patient selection?). 日本泌尿器科学会総会 2025.04.01

Muta Rie, Yoshida Soichiro, Shimoda Hiroki, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Chen Wei, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa. 身体検査時の年齢層別化PSAカットオフ値上昇を伴う症例におけるPHIの有用性(The utility of PHI in cases with elevated age-stratified PSA cutoff values at physical examination). 日本泌尿器科学会総会 2025.04.01

Nakamura Yuki, Murakami Masanori, Matsumoto Shunya, Kobayashi Masaki, Ishikawa Yudai, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yamada Tetsuya, Fujii Yasuhisa. 褐色細胞腫切除後の無症候性低血糖の延長　間欠性スキャニング持続血糖モニタリングを用いた前向き研究(Prolonged asymptomatic hypoglycemia after resection of pheochromocytoma: a prospective study using intermittent-scanning continuous glucose monitoring). 日本泌尿器科学会総会 2025.04.01

Chen Wei, Fukuda Shohei, Yoshida Soichiro, Kobayashi Nao, Fukada Kyohei, Fan Bo, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa. 泌尿器手術におけるAIガイド下ナビゲーションを開拓する　畳み込みニューラルネットワークを用いたロボット支援下根治的膀胱全摘除術におけるリアルタイムureter segmentation(Pioneering AI-guided navigation in urological surgery: real-time ureter segmentation during robot-assisted radical cystectomy using convolutional neural network). 日本泌尿器科学会総会 2025.04.01

Kobayashi Masaki, Shimoda Hiroki, Ito Tsubasa, Matsumoto Shunya, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 根治的前立腺切除術検体における有意癌を予測するためのMRI/US融合生検におけるhighest vs.global Gleason grade groupsの比較(Comparison of highest versus global Gleason grade groups on MRI/US fusion biopsy for predicting significant cancer in radical prostatectomy specimens). 日本泌尿器科学会総会 2025.04.01

Hatori Takumi, Yoshida Soichiro, Muta Rie, Urushido Madoka, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Ishikawa Yudai, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa. 当初、エンザルタミド規定量外投与した去勢抵抗性前立腺癌患者におけるPSA進行後の用量漸増の有効性(Efficacy of Enzalutamide dose escalation after PSA progression in patients with castration-resistant prostate cancer initially treated with modified doses). 日本泌尿器科学会総会 2025.04.01

Ishikawa Yudai, Tanaka Hajime, Muta Rie, Urushido Madoka, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. 原発性筋層非浸潤性膀胱癌に対する経口5-アミノレブリン酸を用いた膀胱腫瘍の経尿道的切除術後の膀胱内再発(Intravesical recurrence after transurethral resection of bladder tumor using oral 5-aminolevulinic acid for primary non-muscle invasive bladder cancer). 日本泌尿器科学会総会 2025.04.01

Yoshida Soichiro, Izumi Keita, Fujiwara Motohiro, Toide Masahiro, Yamamoto Takanobu, Uehar Sho, Araki Saori, Inoue Masaharu, Takazawa Ryoji, Numano Noboru, Ohtsuka Yukihiro, Tanaka Hajime, Fujii Yasuhisa. 内臓転移を伴う同時性および異時性oligometastatic尿路上皮癌患者における転帰と予後因子(Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases). 日本泌尿器科学会総会 2025.04.01

Shimoda Hiroki, Kobayashi Masaki, Ito Tsubasa, Matsumoto Shunya, Nakamura Yuki, Ishikawa Yudai, Chen Wei, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 以前の前立腺生検陰性患者に対するMRI/US融合生検におけるPSA濃度の重要性(Significance of PSA density in MRI/US fusion biopsy for patients with prior negative prostate biopsy). 日本泌尿器科学会総会 2025.04.01

Ishii Kaoru, Ishikawa Yudai, Muta Rie, Urushido Madoka, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 二度目の経尿道的膀胱切除術における経口5-アミノレブリン酸を用いた蛍光膀胱鏡検査の診断能(Diagnostic performance of fluorescent cystoscopy using oral 5-aminolevulinic acid in second transurethral resection of the bladder). 日本泌尿器科学会総会 2025.04.01

Waseda Yuma, Muta Rie, Urushido Madoka, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Ishikawa Yudai, Fukushima Hiroshi, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 上部尿路結石疾患における尿管鏡検査後の腎機能回復を予測する術前腎動脈ドップラーの価値(The value of preoperative renal artery Doppler in predicting renal function recovery after ureteroscopic lithotripsy in upper urinary tract stone disease). 日本泌尿器科学会総会 2025.04.01

Urushido Madoka, Waseda Yuma, Matsumoto Shunya, Koayashi Masaki, Nakamura Yuki, Ishikawa Yudai, Fukushima Hiroshi, Fukuda Shouhei, Tanaka Hajime, Yoshida Souichiro, Fujii Yasuhisa. 上部尿路上皮癌に対する腎尿管摘除術後の腎機能改善の発生率と予測因子(Incidence and predictors of renal function improvement after nephroureterectomy for upper tract urothelial cancer). 日本泌尿器科学会総会 2025.04.01

Fukuda Shohei, Kobayashi Masaki, Matsubara Daigoro, Matsumoto Shunya, Nakamura Yuki, Ishikawa Yudai, Fukushima Hiroshi, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. 一次放射線療法後の局所再発前立腺癌に対する救済局所密封小線源治療(Salvage focal brachytherapy for locally recurrent prostate cancer after primary radiation therapy). 日本泌尿器科学会総会 2025.04.01

Ito Tsubasa, Kobayashi Masaki, Shimoda Hiroki, Matsumoto Syunya, Nakamura Yuki, Ishikawa Yudai, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshidai Soichiro, Fujii Yasuhisa. ダイナミック造影MRIにおける臨床的に有意な前立腺癌の予測に対する造影動態の評価(Evaluation of enhancement kinetics for prediction of clinically significant prostate cancer in dynamic contrast-enhanced MRI). 日本泌尿器科学会総会 2025.04.01

Nakayama Akinori, Fukuda Shohei, Inoue Masaharu, Ito Masaya, Numao Noboru, Tanaka Hajime, Yuasa Takeshi, Koga Fumitaka, Yonese Junji, Kageyama Yukio, Saito Kazutaka, Fujii Yasuhisa. イピリムマブ-ニボルマブ療法が奏効しそうにない明細胞腎細胞癌患者の同定(Identifying clear cell renal cell carcinoma patients who are unlikely to benefit from ipilimumab-Nivolumab therapy). 日本泌尿器科学会総会 2025.04.01

Tanaka Hajime, Fukawa Yuki, Yamamoto Kouhei, Matsumoto Shunya, Kobayashi Masaki, Nakamura Yuki, Ishikawa Yudai, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. UICCT病期分類第8版の検証と改訂の可能性　明細胞腎細胞癌における腎実質性または微小結節型浸潤(Validation of the UICC 8th T Staging and Potential Refinement with Renal Parenchymal Infiltration or Micronodular Spread in Clear Cell Renal Cell Carcinoma). 日本泌尿器科学会総会 2025.04.01

Matsuoka Shotaro, Fukushima Hiroshi, Tanaka Hajime, Inoue Masaharu, Toide Masahiro, Tamiya Takashi, Kawamura Naoko, Izumi Keita, Uehara Sho, Aida Yusuke, Yoshinaga Atsushi, Yoshida Soichiro, Fujii Yasuhisa. 転移性尿路上皮癌患者におけるシスプラチンベース化学放射線療法の既往がペムブロリズマブの有効性に与える影響　YUSHIMA04研究からの結果(Impact of history of cisplatin-based chemoradiotherapy on pembrolizumab efficacy in patients with metastatic urothelial cancer: Results from the YUSHIMA04 study). 日本泌尿器科学会総会 2025.04.01

田中 一, 藤井 靖久. 筋層浸潤性膀胱がん治療の最前線　筋層浸潤性膀胱癌に対する膀胱温存療法　当教室の取り組みと今後の展望. 日本泌尿器科学会総会 2025.04.01

Matsuoka Yoh, Kobayashi Masaki, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Kageyama Yukio, Fujii Yasuhisa. 高齢患者における前立腺癌に対する局所密封小線源治療の腫瘍学的および機能的転帰(Oncological and functional outcome of focal brachytherapy for prostate cancer in older adults). 日本泌尿器科学会総会 2025.04.01

Matsumoto Shunya, Yoshida Soichiro, Muta Rie, Urushido Madoka, Kobayashi Masaki, Nakamura Yuki, Chen Wei, Ishikawa Yudai, Fukushima Hiroshi, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Fujii Yasuhisa. 高解像度CTを用いた腎動脈可視化に対する三次元画像再構築ソフトウェアの比較(Comparison of three-dimensional image reconstruction software for renal artery visualization using high-resolution CT). 日本泌尿器科学会総会 2025.04.01

Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Gaku Okumura, Kaoru Ishii, Shotaro Matsuoka, Takumi Hatori, Hiroki Shimoda, Tsubasa Ito, Madoka Urushido, Rie Muta, Shunya Matsumoto, Masaki Kobayashi, Yuki Nakamura, Yudai Ishikawa, Hiroshi Fukushima, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii. Validation of the UICC 8th T staging system and potential refinement with renal parenchymal infiltration or micronodular spread in clear cell renal cell carcinoma. The 41st Annual EAU Congress 2025.03.23

田中 一, 藤井 靖久. 膀胱癌治療の効果の最大化を目指して　筋層浸潤性膀胱癌に対する膀胱温存療法　患者選択と治療戦略. 日本癌治療学会学術集会抄録集 2024.10.01

Hajime Tanaka. The Emergent Role of Theranostics in Renal Cell Carcinoma. UAA annual congress 2024 2024.09.05

Pavarut Srisopitsawat, 小尾 高史, 李 中淳, 小林 正貴, 田中 一, 石岡 淳一郎, 松岡 陽, 藤井 靖久. マルチモーダル医用画像を使用する腎腫瘍セグメンテーション法の、Transformerネットーワークによる改良(Enhancing Kidney Tumor Segmentation using Multi-Modal Medical Images with Transformer Networks). 日本医用画像工学会大会予稿集 2024.08.01

Yuki Nakamura, Yudai Ishikawa, Shunya Matsumoto, Riko Ikeda, Kasumi Yoshitomi, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Can photodynamic diagnosis-guided biopsy replace bladder mapping biopsy?. AUA annual meeting 2024 2024.05.06

Keita Izumi, Hajime Tanaka, Masataka Yano, Ryoji Takazawa, Akira Noro, Tetsuro Tsukamoto, Junji Yonese, Tesuo Okuno, Yasuyuki Sakai, Fumitaka Koga, Yukio Kageyama, Kazutaka Saito, Yasuhisa Fujii. Real-word outcomes of maintenance chemotherapy versus avelumab therapy after first-line induction chemotherapy for advanced urothelial carcinoma: YUSHIMA study. AUA annual meeting 2024 2024.05.05

Rikuto Yasujima, Hajime Tanaka, Junichi Tsuchiya, Akira Hasegawa, Hiroki Tanaka, Tomoki Kimura, Kotaro Suzuki, Tsubasa Ito, Riko Ikeda, Shunya Matsumoto, Kasumi Yoshitomi,Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Wei Chen, Fan Bo, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Yasuhisa Fujii. Exploring the Role of FDG PET/CT in Predicting Pembrolizumab Response for Metastatic Urothelial Carcinoma. "AUA annual meeting 2024 2024.05.05

Motohiro Fujiwara, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Akira Hasegawa, Tomoki Kimura, Kotaro Suzuki, Hiroki Tanaka, Tsubasa Ito, Rikuto Yasujima, Riko Ikeda, Shunya Matsumoto, Kasumi Yoshitomi, Masaki Kobayashi, Yuki Nakamura, Wei Chen, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Delta-radiomics analysis in comparison to radiomics analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. AUA annual meeting 2024 2024.05.04

Tanaka H, Fujiwara M, Hasegawa A, Tanaka H, Suzuki K, Kimura T, Yasujima R, Ito T, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Fan B, Chen W, Ishikawa Y, Fukuda S, Waseda Y, Yoshida S, Yoshimura R, Kihara K, Fujii Y.. Long-term oncologic outcomes of tetramodal bladder-preservation therapy incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymphnode dissection for muscle-invasive bladder cancer. AUA annual meeting 2024 2024.05.04

田中　一、藤井　靖久. Management and treatment outcomes for intravesical recurrence after bladder preservation therapy for muscle-invasive bladder cancer. 2024.04.27

田中　一、藤原　基裕、小林　正貴、中村　祐基、Fan Bo、石川　雄大、福田　翔平、 早稲田　悠馬、吉田　宗一郎 、吉村　亮一 、木原　和徳、藤井　靖久. Long-term oncologic outcomes of tetramodal bladder-preservation therapy for muscle-invasive bladder cancer. 第111回日本泌尿器科学会総会 2024.04.25

Horie T, Fujiwara M, Hasegawa A, Kimura T, Suzuki K, Tanaka H, Ito T, Yasujima R, Ikeda R, Matsumoto S,Yoshitomi K, Kobayashi M, Nakamura Y, Chen W, Fan B, Ishikawa Y, Fukuda S, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Radiomics analysis using non-contrast computed tomography for predicting HDU admission in patients with acute pyelonephritis. EAU annual meeting 2024 2024.04.08

Tanaka H, Fujiwara M, Hasegawa A, Tanaka H, Suzuki K, Kimura T, Yasujima R, Ito T, Ikeda R, Matsumoto S, Yoshitomi K, Kobayashi M, Nakamura Y, Fan B, Chen W, Ishikawa Y, Fukuda S, Waseda Y, Yoshida S, Yoshimura R, Kihara K, Fujii Y.. Tetramodal bladder-preservation therapy incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymphnode dissection for muscle-invasive bladder cancer: long-term oncologic outcomes of 201 patients. EAU annual congress 2024 2024.04.08

Kenji Tanabe, Shuichiro Kobayashi, Katsyshi Nagashima, Junji Yonese, Yukihiro Ohtsuka, Tetsuo Okuno, Ryoji Takazawa, Akira Noro, Masataka, Yano, Tetsuro Tsukamoto, Kazutaka Saito, Yasuyuki Sakai, Fumitaka Koga, Yukio Kageyama, Hajime Tanaka, Soichiro Yoshida and Yasuhisa Fujii. The Gustave Roussy Immune Score Predicts Survival Outcome of Patients with Metastatic Urothelial Carcinoma Treated with Pembrolizumab: YUSHIMA study. EAU annual congress 2024 2024.04.07

"Tomoki Kimura, Motohiro Fujiwara, Shunya Matsumoto, Kasumi Yoshitomi, Masaki Kobayashi, Bo Fan, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Ryoji Takazawa, Yasuyuki Sakai, Fumitaka Koga, Kazutaka Saito, Masataka Yano, Tetsuro Tsukamoto, Tetsuo Okuno, Yukio Kageyama, Yukihiro Otsuka, Katsushi Nagahama, Yasuhisa Fuji". "Real-world outcomes of first-line systematic treatment in advanced Upper-Urinary Tract Urothelial Carcinoma patients with renal impairment : YUSHIMA-04 study". EAU annual congress 2024 2024.04.05

Motohiro Fujiwara, Daisuke Hirahara, Tatsunori Saho, Eichi Takaya, Akira Hasegawa,Tomoki Kimura, Kotaro Suzuki, Hiroki Tanaka, Tsubasa Ito, Rikuto Yasujima, Riko Ikeda,Shunya Matsumoto, Kasumi Yoshitomi, Masaki Kobayashi, Yuki Nakamura, Wei Chen, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Delta-radiomics analysis in comparison to radiomics analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma. EAU annual meeting 2024 2024.04.05

Tanaka H, Fujii Y.. Presurgical systemic therapy and subsequent cytoreductive nephrectomy (CN). EAU annual congress 2024 2024.04.05

Ishikawa Yudai, Tanaka Hajime, Yoshitomi Kasumi, Fan Bo, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. BCG治療後のPDD-TURBTの診断能の検討(Diagnostic accuracy of fluorescence cystoscopy using oral 5-aminolevulinic acid in transurethral resection of bladder tumor after BCG treatment). 日本泌尿器科学会総会 2024.04.01

Muta Rie, Tanaka Hajime, Araki Saori, Koga Fumitaka, Yonese Junji, Kageyama Yukio, Yano Masataka, Okuno Tetsuo, Noro Akira, Sakai Yasuyuki, Saito Kazutaka, Nagahama Katsushi, Fujii Yasuhisa. 転移性尿路上皮癌に対する一次化学療法後アベルマブ維持療法　治療成績と予後因子の検討(Real-world outcomes and prognostic factors of avelumab maintenance therapy after first-line chemotherapy for metastatic urothelial carcinoma: YUSHIMA study). 日本泌尿器科学会総会 2024.04.01

Yasujima Rikuto, Tanaka Hajime, Tsuchiya Junichi, Yishitomi Kasumi, Kobayashi Masaki, Fujiwara Motohiro, Bo Fan, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. 転移性尿路上皮癌に対するペムブロリズマブ治療効果予測におけるFDG PET/CTの意義　病変単位の解析による検討(Lesion-based analysis exploring the impact of FDG PET/CT findings on treatment response to pembrolizumab in metastatic urothelial carcinoma). 日本泌尿器科学会総会 2024.04.01

Ito Tsubasa, Tanaka Hajime, Matsumoto Syunya, Yoshitomi Kasumi, Fujiwara Motohiro, Kobayashi Masaki, Nakamura Yuki, Fan Bo, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. 転移性尿路上皮癌に対するペムブロリズマブのmixed responseの発生率及び予後への影響(Incidence and prognostic impact of mixed response to pembrolizumab in metastatic urothelial carcinoma). 日本泌尿器科学会総会 2024.04.01

Chen Wei, Tanaka Hajime, Kobayashi Masaki, Fukuda Shohei, Yoshida Soichiro, Saito Kazutaka, Ithaar Derweesh, Master Viraj, Fujii Yasuhisa. 術前CRPを組み込んだ非転移性ccRCCの予後予測ノモグラムの作成と検証　INMARCデータベースに基づく研究(Development and validation of nomograms incorporating preoperative CRP level for prognostic prediction of nonmetastatic ccRCC: result from the INMARC database). 日本泌尿器科学会総会 2024.04.01

Matsumoto Shunya, Waseda Yuma, Ikeda Riko, Yoshitomi Kasumi, Fan Bo, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 腎盂・尿管癌における腎温存手術適応の検討　腎尿管全摘除標本を用いた解析(Investigation of Eligibility for Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma: Risk Stratification Using Radical Nephroureterectomy Specimens). 日本泌尿器科学会総会 2024.04.01

Waseda Yuma, Ikeda Riko, Matsumoto Shunya, Yoshitomi Kasumi, Fan Bo, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 腎機能保護の観点からみた上部尿路結石症診断後の外科的治療介入の最適なタイミング(Optimal timing of surgical intervention after diagnosis of upper urinary tract stone in terms of renal function protection). 日本泌尿器科学会総会 2024.04.01

Tanaka Hajime, Fujiwara Motohiro, Kobayashi Masaki, Nakamura Yuki, Fan Bo, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Yoshimura Ryoichi, Kihara Kazunori, Fujii Yasuhisa. 筋層浸潤性膀胱癌に対する四者併用膀胱温存療法の腫瘍学的長期成績(Long-term oncologic outcomes of tetramodal bladder-preservation therapy for muscle-invasive bladder cancer). 日本泌尿器科学会総会 2024.04.01

Suzuki Kotaro, Ishikawa Yudai, Tanaka Hajime, Matsumoto Shunya, Ikeda Riko, Yoshitomi Kasumi, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fukuda Shohei, Waseda Yuma, Yoshida Soichiro, Fujii Yasuhisa. 筋層浸潤性膀胱癌に対する化学放射線療法後におけるPDD-TURBTの診断能の検討(Diagnostic performance of fluorescence cystoscopy using oral 5-aminolevulinic acid in TURBT after chemoradiation therapy for muscle invasive bladder cancer). 日本泌尿器科学会総会 2024.04.01

Kobayashi Masaki, Tanaka Hajime, Fukuda Shohei, Chen Wei, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Waseda Yuma, Yoshida Soichiro, Master Viraj A., Derweesh Ithaar H., Fujii Yasuhisa. 淡明細胞型腎細胞癌根治術後の転移再発形式および再発後予後と人種の関係(Racial disparities in clinical characteristics of metastatic recurrence after surgery in clear cell renal cell carcinoma). 日本泌尿器科学会総会 2024.04.01

Kobayashi Masaki, Yoshitomi Kasumi, Fan Bo, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 根治的前立腺全摘除後の生化学的再発予測におけるMRI/超音波融合生検によるHighestおよびGlobal Gleason grade groupの有用性の比較(Comparison of the utility of highest vs. global Gleason grade group in MRI-US fusion biopsy for predicting postprostatectomy biochemical recurrence). 日本泌尿器科学会総会 2024.04.01

Fukuda Shohei, Matsumoto Shunya, Yoshitomi Kasumi, Chen Wei, Kobayashi Masaki, Fujiwara Motohiro, Nakamura Yuki, Fan Bo, Ishikawa Yudai, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 外科的切除を受けた非転移性腎細胞癌患者における術前sarcopenia index(血清クレアチニン/シスタチンC比)と予後との関連(Preoperative sarcopenia index based on serum creatinine and cystatin C is associated with prognosis after nephrectomy for non-metastatic renal cell carcinoma). 日本泌尿器科学会総会 2024.04.01

Nakamura Yuki, Ishikawa Yudai, Kobayashi Masaki, Fujiwara Motohiro, Fan Bo, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 光力学診断(PDD)補助下生検は膀胱マッピング生検を代替可能か(Can photodynamic diagnosis-guided biopsy replace bladder mapping biopsy?). 日本泌尿器科学会総会 2024.04.01

Fujiwara Motohiro, Hirahara Daisuke, Saho Tatsunori, Takaya Eichi, Kobayashi Masaki, Nakamura Yuki, Bo Fan, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. 上部尿路上皮癌におけるDelta-radiomics解析の有用性についての検討(Delta-radiomics analysis using dynamic computed tomography for preoperative risk stratification in upper urinary tract urothelial carcinoma). 日本泌尿器科学会総会 2024.04.01

Tanaka Hiroki, Kobayashi Masaki, Yoshitomi Kasumi, Fan Bo, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Fujii Yasuhisa. MRI/US fusion前立腺生検における合併症の頻度　経会陰式生検と経直腸式生検の比較(Comparison of complications in MRI-ultrasound fusion prostate biopsy between transrectal and transperineal approaches). 日本泌尿器科学会総会 2024.04.01

Tanaka Hajime, Fujii Yasuhisa. Future vision of treatment strategies for MIBC: How to standardize the bladder preservation therapy?　筋層浸潤性膀胱癌に対する膀胱温存療法後膀胱内再発の治療と転帰(Management and treatment outcomes for intravesical recurrence after bladder preservation therapy for muscle-invasive bladder cancer). 日本泌尿器科学会総会 2024.04.01

Hasegawa Akira, Fukuda Shouhei, Kobayashi Masaki, Chen Wei, Tanaka Hajime, Waseda Yuma, Yoshida Soichiro, Saito Kazutaka, Derweesh Ithaar H., Master Viraj A., Fujii Yasuhisa. cT1腎細胞癌の診断で腎部分切除または根治的腎摘除を行いpT3aアップステージを認めた症例における術式による予後の差異　国際多施設共同データベース(INMARC)による検討(Outcomes of partial and radical nephrectomy in patients with pathological T3a upstaging of clinical T1 renal cell carcinoma: an analysis from the INMARC Cohort). 日本泌尿器科学会総会 2024.04.01

Izumi Keita, Tanaka Hajime, Yano Masataka, Takazawa Ryoji, Noro Akira, Tsukamoto Tetsuro, Yonese Junji, Okuno Tetsuo, Sakai Yasuyuki, Kageyama Yukio, Koga Fumitaka, Saito Kazutaka, Fujii Yasuhisa. 進行尿路上皮癌に対する一次化学療法後の維持療法の多施設リアルワールドデータの解析　YUSHIMA study(Multicenter real-word data of maintenance therapy after first-line chemotherapy for advanced urothelial carcinoma: YUSHIMA study). 日本泌尿器科学会総会 2024.04.01

Kimura Tomoki, Fujiwara Motohiro, Tanaka Hajime, Yoshida Soichiro, Takazawa Ryoji, Sakai Yasuyuki, Koga Fumitaka, Saito Kazutaka, Yano Masataka, Tsukamoto Tetsuro, Okuno Tetsuo, Kageyama Yukio, Fuji Yasuhisa. 腎機能低下を有する進行尿路上皮癌に対するプラチナベース一次化学療法の治療成績　ゆしまstudy(Real-world outcomes in advanced urothelial carcinoma patients with renal impairment treated with platinum-based first-line chemotherapy: YUSHIMA study). 日本泌尿器科学会総会 2024.04.01

Hajime Tanaka. Presurgical Immune Checkpoint Inhibitors in Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus: Yes or No?. Advancements in Urology: An AUA/JUA Symposium 2024.03.09

田中 一, 藤原 基裕, 吉富 香澄, 小林 正貴, 中村 祐基, 范 博, 石川 雄大, 福田 翔平, 早稲田 悠馬, 吉田 宗一郎, 吉村 亮一, 藤井 靖久. 筋層浸潤性膀胱癌に対する膀胱温存療法の至適対象の探索　膀胱切除検体を用いた検討. 日本癌治療学会学術集会抄録集 2023.10.01

松本 峻弥, 福田 翔平, 吉富 香澄, 范 博, 小林 正貴, 藤原 基裕, 中村 祐基, 石川 雄大, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 古賀 文隆, 影山 幸雄, 藤井 靖久. コロナ禍における膀胱全摘除術前患者に対するオストミービジター遠隔面談の取り組み. 日本癌治療学会学術集会抄録集 2023.10.01

Tanaka Hajime. Renal parenchymal infiltration or micronodular spread in clear cell renal cell carcinoma: prognostic impact and genomic backgrounds. the 110th Annual Meeting of the Japanese Urological Association 2023.04.20

相馬 貴彦, 吉田 宗一郎, 吉富 香澄, 小林 正貴, 范 博, 藤原 基裕, 中村 祐基, 石川 雄大, 福田 翔平, 早稲田 悠馬, 田中 一, 横山 みなと, 藤井 靖久. CRPCの予後予測因子としてのADC値を考慮した腫瘍体積の検討(Tumor diffusion volume according to apparent diffusion coefficient values as a prognostic factor for castration-resistant prostate cancer). 日本泌尿器科学会総会 2023.04.01

会田 祐介, 石川 雄大, 田中 一, 吉富 香澄, 相馬 貴彦, 小林 正貴, 范 博, 藤原 基裕, 中村 祐基, 早稲田 悠馬, 吉田 宗一郎, 横山 みなと, 藤井 靖久. 当院における転移性尿路上皮癌に対するアベルマブを用いた維持療法の初期使用経験(Initial experience of maintenance avelumab for metastatic urothelial carcinoma). 日本泌尿器科学会総会 2023.04.01

金子 香澄, 田中 一, 藤原 基裕, 中村 祐基, 石川 雄大, 福田 翔平, 早稲田 悠馬, 吉田 宗一郎, 横山 みなと, 藤井 靖久. 実臨床での淡明細胞型腎細胞癌患者におけるKEYNOTE-564試験リスクカテゴリーの検証(Evaluation of the risk categories in KEYNOTE-564 trial in patients with clear cell renal cell carcinoma treated in real-world practice). 日本泌尿器科学会総会 2023.04.01

范 博, 横山 みなと, Chen Wei, 小林 正貴, 福田 翔平, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藍 真澄, 伏見 清秀, 藤井 靖久. ロボット支援膀胱全摘除における尿路変向の割合および尿路変向ごとの手術成績　DPCデータベースによる全国調査(Distribution of urinary diversion and surgical outcomes of robot-assisted radical cystectomy: a Japanese nationwide database study). 日本泌尿器科学会総会 2023.04.01

Chen Wei, Yokoyama Minato, Waseda Yuma, Kobayashi Masaki, Fan Bo, Fukuda Shohei, Tanaka Hajime, Yoshida Soichiro, Ai Masumi, Fushimi Kiyohide, Fujii Yasuhisa. Surgical outcomes of robot-assisted radical cystectomy in octogenarian or older patients: a Japanese nationwide study(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

Fukuda Shohei, Saito Kazutaka, Nakayama Akinori, Inoue Masaharu, Tanaka Hajime, Ito Masaya, Numao Noboru, Yuasa Takeshi, Koga Fumitaka, Yonese Junji, Kageyama Yukio, Fujii Yasuhisa. Significance of C-reactive protein flare-response in patient with metastatic renal cell carcinoma treated with first-line immuno-oncology combination therapy. the 110th Annual Meeting of the Japanese Urological Association 2023.04.01

Nakamura Yuki, Fujiwara Motohiro, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Fujii Yasuhisa. Significance of adrenal metastasectomy based on classification of oligometastasis(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

Fujiwara Motohiro, Yoshida Soichiro, Takahara Taro, Soma Takahiko, Yoshitomi Kasumi, Nakamura Yuki, Fan Bo, Ishikawa Yudai, Fukuda Shohei, Waseda Yuma, Tanaka Hajime, Yokoyama Minato, Fujii Yasuhisa. Prostate and Metastasis Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Hormone-naieve Prostate Cancer(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

浅井 真太郎, 小林 正貴, 福田 翔平, 木村 浩一郎, 范 博, 藤原 基裕, 中村 祐基, 石川 雄大, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 横山 みなと, 藤井 靖久. PI-RADS version 2.1における著明な拡散制限を有するatypical noduleのcategory 3へのアップグレードの妥当性(Significance of atypical nodules upgraded to category 3 by abnormal DWI finding in PI-RADS version 2.1 for prostate cancer diagnosis). 日本泌尿器科学会総会 2023.04.01

Yoshida Souichirou, Takahara Taro, Arita Yuki, Toda Kazuma, Kimura Koichiro, Fujiwara Motohiro, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Yoshimura Ryoichi, Fujii Yasuhisa. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

Waseda Yuma, Yokoyama Minato, Yoshitomi Kasumi, Souma Takahiko, Kobayashi Masaki, Fan Bo, Fujiwara Motohiro, Nakamura Yuki, Ishikawa Yudai, Fukuda Shohei, Tanaka Hajime, Yoshida Souichirou, Fujii Yasuhisa. Longitudinal evaluation of lower urinary tract symptoms after artificial urinary sphincter implantation using the core lower urinary tract symptom score(タイトル和訳中). 日本泌尿器科学会総会 2023.04.01

田中 一, 布川 裕規, 山本 浩平, 谷本 幸介, 竹本 暁, 蓮見 壽史, 平川 晃弘, 石川 雄大, 福田 翔平, 早稲田 悠馬, 吉田 宗一郎, 横山 みなと, 藤井 靖久. 淡明細胞型腎細胞癌における腎実質浸潤/進展の意義　予後への影響と遺伝学的背景. 日本泌尿器科学会総会 2023.04.01

横山 みなと, Chen Wei, 小林 正貴, 范 博, 福田 翔平, 早稲田 悠馬, 田中 一, 吉田 宗一郎, 藍 真澄, 伏見 清秀, 藤井 靖久. 膀胱全摘除のトレンドと術式による手術成績の比較　DPCデータベースに基づく全国調査(Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches: A Japanese nationwide database study). 日本泌尿器科学会総会 2023.04.01

Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Izumi H, Uehara S, Matsuoka Y, Yamamoto K, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Ohashi K, Fujii Y. Cribriform cancer is equally visible to non-cribriform cancer on multiparametric MRI: An analysis using texture features. the 37th Annual European Association of Urology(EAU) Congress 2022.07

Fukuda S, Tanaka H, Tanabe K, Tamiya T, Kobayashi M, Yajima S, Nakamura Y, Fujiwara M, Ishikawa Y, Yamamoto T, Araki S, Yoshida S, Yokoyama M, Matsuoka Y, Otsuka Y, Koga F, Fujii Y. Local recurrence following partial nephrectomy in patients with renal cell carcinoma: a multicenter study. The 117th annual meeting of the American Urological Association 2022.05.13 New Orleans, USA

Kobayashi M, Matsuoka Y, Uehara S, Tanaka Hiroshi, Nakamura Y, Uchida Y, Fukuda S, Tanaka Hajime, Yoshida S, Yokoyama M, Fujii Y. PIRADS score combined with positive core number on MRI-ultrasound fusion targeted prostate biopsy can predict the absence of pathological extraprostatic extension. AUA Annual Meeting 2022.05.13

Uchida Y, Yokoyama M, Nakamura Y, Fukuda S, Uehara S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. ASSESSMENT OF ERECTILE AND EJACULATORY FUNCTIONS AFTER BLADDER-SPARING THERAPY AGAINST MUSCLE-INVASIVE BLADDER CANCER. the 22nd World Meeting of the International Society for Sexual Medicine 2022.05

Kimura Koichiro, Yoshida Soichiro, Tsuchiya Junichi, Tanaka Hajime, Yokoyama Minato, Matsuoka Yoh, Fujii Yasuhisa, Yoshimura Ryoichi, Tateishi Ukihide. 筋層浸潤膀胱癌に対する膀胱温存療法の治療効果予測におけるVI-RADSの臨床的意義(Clinical Significance of the Vesical Imaging Reporting and Data System in Predicting the Therapeutic Effect of Bladder-Sparing Treatment in Muscle-Invasive Bladder Cancer). 日本医学放射線学会学術集会抄録集 2022.03.01

Tanaka Hajime. Prognostic impact of pathological renal parenchymal infiltration in non-metastatic clear cell renal cell carcinoma. AUA Annual Meeting 2022

Tanaka Hajime. Renal parenchymal infiltration is the primary determinant of prognosis of patients with non-metastatic clear cell renal cell carcinoma. 37th Annual EAU Congress 2022

Tanaka Hajime. Disparities in Cancer-Specific Mortality between Asian and Caucasian Patients with Non-metastatic Renal Cell Carcinoma: Analysis of the INMARC registry. 37th Annual EAU Congress 2022

上原 翔, 松岡 陽, 山本 くらら, 戸出 真宏, 内田 裕將, 福田 翔平, 福島 啓司, 安田 庸輔, 田中 一, 吉田 宗一郎, 横山 みなと, 大橋 健一, 藤井 靖久. 前立腺の篩状癌と腺管内癌の検出におけるMRI標的生検の有用性(Usefulness of MRI-targeted biopsy in detecting cribriform carcinoma and intraductal carcinoma of the prostate). 日本泌尿器科学会総会 2021.12.01

山口 良友, 田中 一, 福島 啓司, 戸出 真宏, 内田 裕將, 福田 翔平, 安田 庸輔, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久. 原発性腎腫瘍の放射線学的浸潤性特徴が転移性腎細胞癌の予後へ及ぼす影響(Prognostic impact of radiologic infiltrative feature of primary renal tumor in metastatic renal cell carcinoma). 日本泌尿器科学会総会 2021.12.01

田中 一, 島田 航, 布川 裕規, 木村 浩一朗, 山本 浩平, 福田 翔平, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 立石 宇貴秀, 藤井 靖久. 局所進行腎細胞癌における正常腎実質浸潤の意義　画像および組織学的所見に基づく考察. 日本癌治療学会学術集会抄録集 2021.10.01

田中　一. Significance of Radiologic Infiltrative Feature of Primary Renal Tumor in Predicting Patient Survival in Metastatic Renal Cell Carcinoma. AUA Annual Meeting 2021.09.10 web

Tanaka Hajime. Prognostic significance of radiologic infiltrative feature of primary renal tumor in metastatic renal cell carcinoma. 36th Annual EAU Congress 2021.07.10 web

福島啓司、木島敏樹、吉田宗一郎、横山みなと、石岡淳一郎、松岡陽、斎藤一隆、松原伸晃、湯浅健、増田均、米瀬淳二、影山幸雄、藤井靖久. 進行尿路上皮癌症例におけるペムブロリズマブの治療効果及び予後：化学放射線療法の治療歴との関連. 第108回 日本泌尿器科学会総会 2020.12.24

Uehara Sho, Matsuoka Yoh, Tanaka Hiroshi, Fukuda Shohei, Fukushima Hiroshi, Moriyama Shingo, Tanaka Hajime, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Saito Kazutaka, Fujii Yasuhisa. 標的外のsystematic biopsy coreは前立腺がんの有意な検出に対して限定的な意義しかない　MRI多平面再構築を用いた分析(Systematic biopsy cores apart from targets are of limited value for significant prostate cancer detection: Analysis using MRI multiplanar reconstruction). 日本泌尿器科学会総会 2020.12.01

Kijima Toshiki, Tanaka Hajime, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Masuda Hitoshi, Matsubara Nobuaki, Yuasa Takeshi, Yonese Junji, Kageyama Yukio, Fujii Yasuhisa. 進行性尿路上皮がん患者における免疫関連有害事象とpembrolizumabの有効性の関連性(Association between immune-related adverse events and efficacy of pembrolizumab in advanced urothelial cancer patients). 日本泌尿器科学会総会 2020.12.01

Tanaka Hajime, Shimada Wataru, Fukuda Shohei, Fukushima Hiroshi, Uehara Sho, Moriyama Shingo, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa. 臨床的に限局性の腎細胞癌の腫瘍学的転帰の予測における腫瘍不定形性形状の意義(Significance of tumor shape irregularity in predicting oncologic outcomes of clinically localized renal cell carcinoma). 日本泌尿器科学会総会 2020.12.01

田中 一, 木島 敏樹, 福田 翔平, 福島 啓司, 安田 庸輔, 森山 真吾, 上原 翔, 吉田 宗一郎, 横山 みなと, 松岡 陽, 藤井 靖久. 局所限局性浸潤性膀胱癌の実践治療　筋層浸潤膀胱癌に対する4者併用膀胱温存療法. 日本癌治療学会学術集会抄録集 2020.10.01

福島 啓司, 木島 敏樹, 安田 庸輔, 森山 真吾, 上原 翔, 田中 一, 吉田 宗一郎, 横山 みなと, 松岡 陽, 松原 伸晃, 湯浅 健, 増田 均, 米瀬 淳二, 影山 幸雄, 藤井 靖久. 進行・転移性膀胱癌治療のup-to-date　進行尿路上皮癌に対するペムブロリズマブ治療における化学放射線療法の意義. 日本癌治療学会学術集会抄録集 2020.10.01

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who benefits from extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Stereological analysis of biopsy-proven cancer sites. The 35th Annual Congress of the European Association of Urology 2020.07.17 Amsterdam Netherlands.

Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Who needs extra-target sampling in addition to intra-target sampling for the detection of adverse prostate pathology?: Spatial analysis of biopsy-proven cancer sites. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

Matsuoka Y, Ishioka J, Tanaka H, Fukuda S, Fukushima H, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Saito K, Fujii Y. Apparent diffusion coefficient ratio as a quantitative imaging marker: Utility in a nomogram for predicting biochemical recurrence after radical prostatectomy. The 115th annual meeting of the American Urological Association 2020.05.15 Washington DC, USA

Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Yoshida S, Taniguchi N, Moriyama S, Uehara S, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. . Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy.. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores near targets are of value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction.. The 12th international symposium on focal therapy and imaging in prostate and kidney cancer, 2020 2020 Washington DC, USA

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores apart from targets are of limited value for the detection of significant cancer: Analysis of prostate biopsy mapping using multiplanar MRI reconstruction. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Uehara S, Matsuoka Y, Tanaka H, Moriyama S, Tanaka H, Kijima T, Yoshida Y, Yokoyama M, Ishioka J, Saito K, Fujii Y. Systematic biopsy cores away from targets are of limited value for the detection of significant cancer: Analysis of 3D prostate biopsy mapping using multiplanar MRI reconstruction.. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Toide M, Tanaka H, Uchida Y, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Stepwise diagnostic algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses: Prospective validation study. The 35th Annual Congress of the European Association of Urology, 2020 2020 Amsterdam, Netherlands

Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Novel classification model of tumour shape irregularity: significance for predicting potential oncologic risks in clinically localised renal cell carcinoma. The 35th Annual Congress of the European Association of Urology, 2020 (Virtual) 2020

Moriyama S, Yokoyama M, Nakamura Y, Fukuda S, Fukushima H, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of nocturia on deteriorated renal function after adrenalectomy in patients with primary aldosteronism. 114th annual meeting of the American Urological Association, 2020 2020 Washington DC, USA

Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing’s syndrome. The 35th Annual European Association of Urology Congress Virtual, July 2020 2020

Tanaka H, Shimada W, Fukuda S, Fukushima H, Moriyama S, Uehara S, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Campbell SC, Fujii Y. Significance of tumor shape irregularity for predicting potential oncologic risks in clinically localized renal cell carcinoma. The 114th Annual Meeting of the American Urological Association, 2020 (Virtual) 2020

Fukushima H, Kijima T, Uehara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Previous chemoradiotherapy may enhance the efficacy of pembrolizumab in advanced urothelial carcinoma patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam, Netherlands

Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Tanaka H, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal change in urinary incontinence, lower urinary tract symptoms and quality of life after artificial urinary sphincter implantation. 114th annual meeting of the American Urological Association 2020 Washington DC, USA

Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Low incidence of perioperative infections without antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: a prospective single-institutional study of 1339 patients. The 115th annual meeting of the American Urological Association 2020 Washington DC, USA

Maruyama R, Fukushima H, Fukuda S, Moriyama S, Uehara S, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility of non-use of antimicrobial prophylaxis in clean urologic surgeries for adrenal and renal tumors: A prospective single-institutional study of 1339 patients. The 35th Annual Congress of the European Association of Urology 2020 Amsterdam Netherlands

Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. 113th annual meeting of the American Urological Association 2019.05.06 Chicago, USA.

Yoshida S., Tanaka H, Kijima T., Yokoyama M., Ishioka J., Matsuoka Y., Saito K., Kihara K., Fujii Y.. Vesical Imaging-Reporting And Data System (VI-RADS) for bladder cancer staging with multiparametric MRI.. The 34th Annual Congress of the European Association of Urology 2019.03.17 Barcelona, Spain.

1 Yasuda Y, Saito K, Soma T, Tanaka H, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y. The outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. he outcome of gasless laparoscopic single-port clampless sutureless partial nephrectomy using three-dimensional head-mounted display. The 112th annual meeting of the American Urological Association 2018.05.18 San Francisco, USA

Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients. The 33th European Association of Urology annual congress 2018.03.26 Copenhagen, Denmark

Kaneko K, Yoshida S, Takahara T, Sakamoto T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Diffusion-weighted MRI as an imaging biomarker for histological grade of bladder cancer: Semi-automatic segmentation analysis. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Waseda Y, Yoshida S, Takahara T, Arita Y, Sakamoto T, Yajima S, Uehara S, Yasuda Y, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y.. Feasibility of perfusion MRI to predict renal function after nephroureterectomy in upper tract urothelial carcinoma patients.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Yoshida S, Matsuoka Y, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y. . Head-mounted display assisted magnetic resonance/ultrasound fusion prostate biopsy system.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Yoshida S, Tanaka H, Yasuda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. . Prediction of intraoperative urinary collecting system entry in patients with peripheral renal tumors undergoing partial nephrectomy: Usefulness of tumor-centered multiplanar reconstruction.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Uehara S, Matsuoka Y, Tanaka H, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Do the Prostate Imaging Reporting and Data System scores reflect oncological outcome? Potential usefulness of scoring criteria-based assessment. . 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Clinical significance of MRI-targeted biopsy in prediction of adverse pathological and oncological outcome after radical prostatectomy.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Matsuoka Y, Tanaka H, Kimura T, Waseda Y, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Saito K, Kihara K, Fujii Y.. Characteristics of global Gleason grading for MRI-targeted biopsy in comparison with systematic biopsy and prostatectomy grades.. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.19 Copenhagen, Denmark

Soma T, Ihioka J, Tanaka H, Uehara S, Yasuda Y, Kijima T, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Kihara K, Fujii Y. Computer-aided differential diagnosis of fat-poor angiomyolipoma using a deep neural networks algorithm in enhanced CT and T2-weighted magnetic resonance imaging. 欧州泌尿器科学会（The 33th European Association of Urology annual congress, Copenhagen, Denmark） 2018.03.17 Denmark

Matsuoka Y, Tanaka H, Kimura T, Ito M, Inoue M, Kijima T, Yoshida S,. MRI-targeted biopsy vs. systematic biopsy in prediction of biochemical　recurrence after radical prostatectomy. 第105回日本泌尿器科学会総会 2017.04.21 Kagoshima

田中一,吉田宗一郎,井上雅晴,伊藤将也,木島敏樹,横山みなと,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 膀胱癌の免疫組織化学染色に基づく分子サブタイプ分類と化学放射線療法感受性及び予後の解析：筋層浸潤膀胱癌に対する新たな治療戦略に向けて. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

川村尚子,横山みなと,中山貴之,田中一,井上雅晴,伊藤将也,木島敏樹,吉田宗一郎,石岡淳一郎,松岡陽,齋藤一隆,木原和徳,藤井靖久. 無阻血腎部分切除後の急性腎障害：発生率と術後腎機能への影響. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島、日本

吉田宗一郎、高原太郎、石井千佳子、田中一、井上雅晴、伊藤将也、木島敏樹、横山みなと、石岡淳一郎、松岡陽、齋藤一隆、木原和徳、藤井靖久. DWIBS法による全身拡散強調MRIを用いた去勢抵抗性前立腺癌の予後評価. 第105回日本泌尿器科学会総会 2017.04.21 鹿児島

Nakamura Yuki, Tanaka Hajime, Fujii Yasuhisa, Inoue Masaharu,　Ito　Masaya,　Kijima　Toshiki,　Yoshida　Soichiro,　Yokoyama　Minato,　Ishioka　Junichiro,　Matsuoka Yoh, Saito Kazutaka, Kihara Kazunori. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: A comparison of oncological outcomes between primary and progressive diseases. . 32nd Annual EAU Congress 2017.03.27 London, UK

Matsuoka Y, Ishioka J, Tanaka H, Kimura T, Inoue M, Ito M, Kijima T, Yoshida. Characteristics of MRI staging using PI-RADS version 2 and its predictive performance for biochemical recurrence after radical prostatectomy compared to PI-RADS version 1. 32nd Annual EAU Congress 2017.03.27 London

N. Kawamura, M. Yokoyama, T. Nakayama, H. Tanaka, M. Inoue, M.Ito, T. Kijima, S. Yoshida, J. Ishioka, Y. Matsuoka, K. Saito, K. Kihara,Fujii Y.. Acute kidney injury after clampless partial nephrectomy:incidence, predictors, and its low impact on intermediate-term renalfunction　. 32nd Annual EAU Congress 2017.03.27 London、England

13.Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses.. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.09 San diego, USA

Masaharu Inoue, Fumitaka Koga, Soichiro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Predictive model for therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiotherapy-based bladder-sparing protocol. AUA2016 Annual Meeting 2016.05.09 San Diego, USA

Fujii Y et al.. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.08 USA

Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07

Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego

Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Germany

Inoue M et al. . Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. . 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.14 Munich, Germany

Masaharu Inoue, Fumitaka Koga, Soiciro Yoshida, Hajime Tanaka, Shuichiro Kobayashi, Masaya Ito, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Noboru Numao, Kazutaka Saito, Yasuhisa Fujii, Kazunori Kihara. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labeling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. the 31st Annual EAU Congress 2016.03.14

1.Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. . Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients.. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Germany

Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13 Munich, Germany

Waseda Y. et al.. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma. 欧州泌尿器科学会（European Association of Urology annual congress） 2016.03.13

Fujii Y., Kihara K., Tanaka H., Tatokoro M., Yoshida S.m Yokoyama M., Ishioka J., Matusoka Y., Numao N., Saito K. Oncological and functional outcomes in muscle-invasive bladder cancer patients undergoing bladder-sparing treatment consisting of low-dose chemoradiotherapy and consolidative partial cystectomy. The 111th annual meeting of the American Urological Association 2015.05.18 New Orleans, USA

Tanaka H., Fujii Y., Ito M., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K., Yonese J., Kihara K. Development and validation of a novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 111th annual meeting of the American Urological Association 2015.05.15 New Orleans, USA

Tanaka H, Fujii Y, Ito M, Tatokoro M, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Yonese J, Kihara K. Novel prediction model for fat-poor angiomyolipoma in small renal masses based on radiological and clinical features. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

14.Fujii, Y., Kihara, K., Numao, N., Tanaka H., Tatokoro M., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Numao N., Saito K. Selective bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: oncological and functional outcome. The 30th Annual Congress of the European Association of Urology 2015.03.22 Madrid, Spain

Hajime Tanaka, Soichiro Yoshida, Yoshinobu Komai, Tatsuro Hayashi, Mizuaki Sakura, Shinji Urakami, Tokyo, Japan, Yasuyuki Sakai, Chiba, Japan, Takeshi Yuasa, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese, Yasuhisa Fujii, Kazunori Kihara. The value of 18 F-FDG PET/CT in staging of upper tract urothelial carcinoma: impact on patient management. . AUA Annual Meeting 2014 2014.05.16